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PREFACE 
 
The Health Economics Research Group (HERG) at Brunel University is involved in a long-
term programme analysing the benefits from health research, with an emphasis on the 
payback from health services research. This programme is being expanded, in collaboration 
with colleagues working on these issues elsewhere, to include exploration of methodologies 
for assessing the impact from basic or early clinical biomedical research. A central 
collaborator is Jonathan Grant, formerly Head of Policy at the Wellcome Trust, and now at 
RAND Europe. In simultaneously publishing two reports in the HERG Research Report 
series we bring together several elements of this research, and draw on them to make 
proposals for further work. 
 
In HERG Research Report 30, From Bedside to Bench: Comroe and Dripps Revisited, Grant 
et al examine whether it is possible to replicate, and validate, the pioneering work of Comroe 
and Dripps in the 1970s. The latter traced back from then current clinical practice to the 
knowledge behind the advances. They claimed that more than half of the articles identified 
as making a key contribution to the clinical advances resulted from basic research. The 
attempted replication proved difficult, but Grant et al describe how they developed and 
applied an alternative methodology. 
 
In HERG Research Report 31, From Bench to Bedside: Tracing the Payback Forwards from 
Basic or Early Clinical Research--a Preliminary Exercise and Proposals for a Future Study, 
Hanney et al describe a joint HERG/Wellcome Trust project that in part builds on the 
emerging findings from Grant et al’s study of the Comroe and Dripps methodology. 
Recognising the difficulties in tracing backwards from clinical practice, the project described 
here attempts instead to work forwards by tracing the impact from research conducted 20 
years ago. Having described how the methods were applied in a preliminary study, the 
report goes on to outline how the work could be developed in a larger study. 
 
The research undertaken for both reports was primarily funded by the R&D Directorate of the 
NHS Executive London, whose Director of R&D, Sally Davies, has been a stalwart supporter 
of such research and of its aim to provide an evidence-base for health research funding 
policies. 
 
Martin Buxton 
Health Economics Research Group 
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EXECUTIVE SUMMARY 
 
 
Chapter 1 : Introduction 
• The members of the research team from HERG and the Wellcome Trust have conducted 
previous studies showing that it is possible both to assess the payback from applied 
health research, and to use bibliometrics to trace the links between generations of 
research and clinical guidelines. In another of the team’s studies, however, it proved 
difficult to replicate the major study by Comroe and Dripps (1976) that had identified 
clinical advances and then worked backwards to show that they had relied on earlier 
basic research. Therefore, the study reported here sets out to use the methods 
developed in our previous studies of payback to undertake analysis that starts with more 
basic or early clinical research and traces the research lines forwards to clinical 
applications. Whilst this preliminary study involved preparation for a future large-scale 
study, it was hoped that it would also provide an interesting case study. 
• Starting with the research outputs of one team 20 years ago, called the 1st generation 
papers, the preliminary study has three main elements: standard bibliometric analysis 
through several generations of papers; categorisation of the citations; and qualitative 
analysis using questionnaires, critical pathway analysis and interviews to trace the 
impact of the 1st generation of research. 
• Diabetes and cardiology were suggested as possible topics on which to base the study. 
Initial reviews identified two bodies of research in diabetes as being potentially suitable 
for reasons such as the continuing activity of key members of the team.  
• The research into diabetes conducted in 1981 by George Alberti and his team at 
Newcastle, and collaborators elsewhere, was selected to provide the case study for this 
preliminary stage for several reasons. It was thought to have been important science and 
there was a belief that some of it had made a contribution to clinical practice. 
 
Chapter 2 : Bibliometric analysis 
• An original plan to look at publications produced over a three year period was changed 
to looking at the output of just one year, 1981, because in that year alone Alberti and 
colleagues published 29 articles. These form the 1st generation papers and the average 
number of citations they received is high. Identifying the citations given to these 29 
papers resulted in 799 2nd generation papers and 12,891 3rd generation papers. The 
numbers involved meant that it was impractical to go beyond the 3rd generation. Within 
the high overall average, the variation in the number of citations per paper was 
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considerable going from 76 to just one.  Similarly, the half-lives of the 29 papers, ie the 
time taken for an article to receive 50% of its citations, ranged from two years to 11. 
• Articles can be given a Research Level (ie one of four levels from clinical observation to 
basic) based on the journals in which they appear. Such analysis demonstrates the 
breadth of Alberti’s work because the 29 articles are spread across all four Research 
Levels.  Crucially, there was not a shift from basic to more clinical levels across the 
generations.  The higher than average number of authors and addresses per paper is 
testimony to Alberti’s extensive collaborations. 
• The funding acknowledgements reveal the high proportion of papers supported, at least 
partially, by one funder: the British Diabetic Association, now Diabetes UK, which 
provided core support for Alberti’s Newcastle team.  
 
Chapter 3 : Categorisation of citations 
• Traditional citation analysis does not allow identification of the importance of the cited 
article to the citing article, and therefore limits the ability to use citation analysis to trace 
the impact of basic or early research on later research. We conducted a review of the 
literature of the meaning of citations.  
• From this review, a template was devised that allowed the location, nature and 
importance of citations to be recorded as well as the type of research (basic or clinical) 
described in the paper. This was used by six assessors on a sample of papers and 
inter-rater reliability was tested. Further work is required to refine the template and its 
definitions, and to improve its consistency in application.  
• Nevertheless, for initial analysis, it was applied to 623 out of the 799 2nd generation 
papers. A four point scale was used for the importance of the cited paper to the citing 
paper. In just 9% of cases was the cited 1st generation paper thought to be in one of the 
top two categories, ie of Considerable or Essential importance to the citing paper. 
• Statistical analysis revealed no relationship between the number of citations a paper 
received and the proportion of citations where the cited paper was classified as being of 
high (ie. Considerable or Essential) importance to the citing paper. Self-citations, 
however, were shown to be significantly more likely to be in this category.  
• The classification of the type of research (basic or clinical) by our analysis of each paper 
broadly agreed with the classification of the journals by Research Level.  
• The time constraints involved in applying the template, plus the lack of any overall 
pattern in terms of correlations between number and importance of citations, might point 
to the desirability of adopting a more selective approach, guided by qualitative analysis. 
In any selective approach, however, it is likely that self-citations should feature. 
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Chapter 4 : Qualitative analysis 
• Given the number of co-authors, it seemed appropriate to send them a questionnaire 
rather than attempt to interview them. Therefore the interviewing was rather more 
concentrated than originally intended. Only one formal critical pathway was created, but 
it was undertaken by an expert in the field who worked with Alberti at Newcastle.  
• Some problems emerged in taking 1981 as the starting point for the study. Alberti 
identified 10 selected papers from the 1970s and 1980s that he felt had had most impact 
on clinical practice. These helped to give us both a better understanding of the payback 
from our 1st generation, or 1981, papers, and provided further material for analysis. 
• Attempting to describe the impact from the 1981 body of work, and from the 10 selected 
papers, underlines the complex reality of how science advances and influences clinical 
practice. If they make a contribution at all, most studies make a small, incremental one.  
• A few papers, however, have been shown to have a considerably greater impact. A 
possible key to the level of payback indicated is the enormous breadth of Alberti’s 
contacts, and fields and methods of working, to which various references were made. 
This is well illustrated in the account of how the idea for subcutaneous pumps came 
about. Similarly, the ability to produce the very important guidelines on treating diabetics 
during surgery, and diabetic coma, partly resulted from the application to clinical 
problems of the understandings gained from some of the basic/early clinical studies.  It is 
significant that the key papers on these issues, all of which come from the list of 10 
selected papers from the 1970s and 1980s, were having an impact on the 1981 work.  
• How far the collection of papers from 1981 have been drawn upon in similar ways is less 
clear. Nevertheless, papers on treating diabetics during open heart surgery, and on 
bolus delivery of insulin at meal times, were key parts of these wider streams, despite 
variable citation levels. Furthermore, various papers, including on acarbose, on portal 
infusion of insulin, and on semi-human insulin, were important steps in bodies of work in 
their respective areas. The complexity was illustrated by a paper that helped debunk the 
Chlorpropamide alcohol flushing hypothesis, and thus end a line of scientific enquiry: 
there was payback in stopping an incorrect line of inquiry, but nothing on which to build. 
• Each technique in the qualitative study produced information about the successful 
subsequent careers followed by many researchers trained through working with Alberti. 
• Historical perspectives, and insider expert opinions, were important in the qualitative 
analysis. Overall, the qualitative methods highlighted some limitations in the bibliometric 
approach but also showed how aspects of the citation analysis can complement the 
opinions expressed, for example about the importance of the breadth of Alberti’s work.  
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Chapter 5 : Lessons learnt and the way forward 
• Lessons learnt: a variety of methods can be used successfully to gather considerable 
data about the payback from a body of research undertaken 20 years ago. Traditional 
citation analysis alone, however, is not sufficient: the importance of the surgery papers 
despite their relatively low citation rates illustrates this. The qualitative methods are 
important and much of the analysis is strengthened by drawing on multiple approaches. 
Several problems remain, including: identifying a coherent starting point for the analysis; 
coping with the enormous number of papers involved in later generations; and refining 
the template for categorising citations and developing ways of fully utilising the results 
from applying it.  
• Preparing for the large-scale study: this preliminary study provides a basis on which to 
attempt to undertake the larger study we envisaged. Issues now being addressed 
include identification of the level of bibliometric/citation analysis necessary to 
complement any qualitative studies. To provide confidence in the findings from an 
eventual large-scale study, we will need to expand the focus. The study will need to 
cover at least four sets of case studies. Ideally, each set should focus on a number of 
research groups working in a country in the same field. We hope there will be sets of 
case studies in two or three fields and in at least two countries. The issues to be 
explored will include ones highlighted by this study such as breadth of work, level of 
collaboration, and the role of core funding. 
• Methods for the large-scale study: for each case study we now propose to employ two 
methodological elements based on the qualitative and quantitative techniques adopted in 
the preliminary study. They will work in parallel but the quantitative bibliometric analysis 
would be applied selectively to parts of ‘research lines’ (ie discrete themes of research) 
identified in the qualitative studies as being important in influencing clinical practice. 
•  Presenting the findings: each research line could be written-up in a standardised 
document that would use the HERG payback model and categories to describe the 
impact of that research.  We shall use the qualitative and quantitative data to compare 
and contrast the ‘payback’ of research lines by country and disease, and then identify 
common factors that correlate with the translation of basic or early clinical research.  
• Concluding comments: in the era of ‘evidence based policy’, research funders are 
looking for value for money in the research they support and for evidence on the 
effectiveness of different research strategies. In this study we have begun developing a 
methodology that will allow us to understand the complexity of research development 
over a series of generations.  The utility of the policy research we propose here will only 
be realised when it is scaled up to cover a number of different fields in different settings.  
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 1 INTRODUCTION  
 
1.1 Background 
How to assess the utilisation or impact of health research, and the payback or benefits from 
it, is an issue of growing importance to national and international bodies (Raiten and 
Berman, 1993; Buxton and Hanney, 1998; National Institutes of Health, 2000; COHRED, 
2000; Smith, 2001; WHO, 2002; van Weel, 2002; Royal Netherlands Academy of Arts and 
Sciences, 2002; Pang et al, forthcoming). A number of studies have now shown that it is 
possible to make an ad hoc assessment of the payback, or impact on policy or practice, of 
specific examples of applied ‘health services research’  (Buxton and Hanney, 1994, 1996 
and 1997; Buxton et al, 1999; Jacob and McGregor, 1997).  Increasingly, the view is being 
adopted that such approaches should form part of the regular process of assessing research 
and thus contribute to the justification for further funding  (Buxton, Croxson and Hanney, 
1999; Croxson et al, 2000; Smith, 2001).  
 
There remains, however, a belief that these techniques cannot be applied or adapted to 
address the much more long-term and indirect impact that basic science or early clinical 
research may eventually have on health service practice and policies (Cozzens, 1997).  This 
in turn leads to a dilemma.  One option is that basic research will be exempt from 
consideration of its impact, so making the ‘quality of its science’ the only criterion for such 
work.  Such a position would negate much of the logic of such initiatives as the UK Foresight 
Exercise (OST, 1993) and may give, or appear to give, an unfair advantage to basic 
research relative to more applied research.  Alternatively, the impact of basic science will be 
measured in some way but without any real understanding of how impact occurs, or how it 
might be best assessed: such an uninformed situation could potentially disadvantage more 
basic science research relative to applied research, or lead to a distortion of priorities. 
 
There has been the occasional one-off study, including an attempt to integrate cost-benefit 
analysis with historical tracing of the important science developments leading up to the 
discovery of the methodology for producing monoclonal antibodies (Raiten and Berman, 
1993). Furthermore, the National Institutes of Health (NIH), as part of their report under the 
Government Performance and Review Act, take various approaches to accounting for the 
way in which their funding has been spent. They not only provide brief accounts of specific 
scientific findings described in individual papers linked to NIH funding, but also two page 
vignettes describing the longer history of certain issues and recent advances (NIH, 2000). 
These are called ‘Stories of Discovery’.  These stories do not amount, however, to a 
systematic attempt to assess the payback from research. 
 2 
It has been suggested that clinical guidelines can be viewed as one form of secondary 
output from health research (Buxton and Hanney 1996). Taking this concept, it is possible to 
study the nature of the evidence base of such guidelines by examining the citations included 
in them, and then, in turn, to consider the citations in those papers (Grant, 1999; Grant et al, 
2000 - see also Lewison and Wilcox-Jay, 2003). This form of working backwards from 
desirable impacts of the research partially builds on the classic study conducted in the USA 
in the 1970s. That study entailed working backwards from then recent clinical advances to 
uncover the research that lay behind them (Comroe and Dripps, 1974; Comroe and Dripps, 
1976).  Although a one-off and imperfect study, ‘Comroe and Dripps’ is often cited as an 
irrefutable indication of the breadth and unpredictability of how basic science will eventually 
be applied. Attempts to replicate the Comroe and Dripps study (Mason et al, 2001; Grant et 
al, 2003) suggest that starting with clinical advances, and attempting to understand the 
linkages back to basic research, involves too many assumptions.1  
 
It has been proposed instead that our understanding of this important area would be 
valuably informed by undertaking studies that start with the more basic, or early clinical, 
science and try to trace them through to applications (Buxton and Schneider, 1999). Along 
similar lines, a major review of the role of citations suggested that: 
'One largely unutilized role of citations is to serve as a "radioactive tracer" of 
research impacts.  Citations allow the analyst to track the documented flow and 
evolution of research over time until the linkages to far downstream products 
can be identified. Because of the potential information available from the 
tracking application, this is a very fruitful area for future citation research and 
analysis'.  (Kostoff, 1998, pp 29-30). 
 
For this current project, we identified various approaches for undertaking this process of 
looking forward (with hindsight). These included an essentially quantitative analysis of 
literature and citations involving both mechanical tracing of citations and a categorisation of 
the citations found, and a more qualitative approach drawing on the opinions of researchers 
and experts through questionnaires and interviews.2 
 
                                                          
1 Diabetes UK also explored with the Policy Unit of the Wellcome Trust the possibility of undertaking a 
study that worked backwards from current clinical advances. They, too, found that it soon became 
apparent that the number of papers involved would be overwhelming. 
 
2 Support for the integration of scientometric methods into a qualitative study of science has come 
recently from Gläser and Laudel (2001), but they examined a rather different issue than the one of 
concern here. 
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1.2 Potential large-scale study 
Our medium-term objective is to undertake a large study that would use these approaches to 
trace the impact of a number of discrete bodies of clinical/basic research, probably identified 
in terms of a body of funded research undertaken by an individual or clearly identifiable 
research group.  The aim would be to assess the impact of several such bodies of research, 
probably work undertaken about twenty years ago funded by research agencies in the UK 
and abroad.  We envisage that a number of funding agencies whose funded research would 
be studied would be approached jointly to fund such a large-scale study. 
This research could make a major contribution to our understanding of the way that results 
of basic or clinical research (specific findings, ideas, concepts or methodological 
approaches) eventually feed through into application. It might thus provide a basis for 
proposing indicators of likely future impact, say in terms of the nature of the citations 
received and the type of journals in which they occur.   
1.3        Preliminary study 
Before embarking on any such large-scale multi-agency study, it was important to test the 
key components of our proposed methodology. It was thought that if the various elements 
were undertaken together they would be mutually supportive, help to establish the feasibility 
of a major study, and identify the most appropriate methods, scope, costs and time-scale. 
Additionally, it was hoped that if this preliminary study focussed on a body of research of real 
interest and import, it could also provide an interesting case study in its own right. 
 
The preliminary study reported here was funded by the London Regional Office of the NHS 
whose Director of R&D, Sally Davies, suggested diabetes or cardiology might be appropriate 
areas in which to conduct the study. It was judged that we needed to follow research for at 
least 20 years. Initial reviews quickly established two bodies of research in diabetes that had 
been conducted 20 years ago that might be suitable. Of the two teams, the one based at 
Newcastle and led by George (now Sir George) Alberti was identified as most suitable 
because of the importance of the work and the belief that some contribution to clinical 
practice had occurred. The intention was that papers from the three years 1981-83 would be 
studied, but the high productivity of Alberti and his various collaborators, and the high 
average level of citations to the papers, meant that it rapidly became clear that the 
preliminary study could focus on only one year. The base year, 1981, was chosen.  
 
The study was conceived as having three main elements and these are considered in turn in 
each of the next three chapters: 
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• standard bibliometric analysis; 
• categorisation of citations; 
• qualitative analysis. 
 
The scale of the bibliometric analysis described in Chapter Two was immense. The various 
techniques were not just applied to the initial body of 29 papers from 1981 (the 1st 
generation) but also to papers that cited them. The citations were traced through several 
generations and numbered almost 13,000 in the 3rd generation.  
 
Citation analysis is widely undertaken but nevertheless subject to frequent criticism. Part of 
the unease is the lack of certainty about what meaning can be attached to citations and thus 
to citation scores. Chapter Three starts by describing a variety of previous studies that have 
attempted to analyse citation behaviour with the aim of better understanding its meaning. 
The review was used to inform the development of a template to be applied to the citations. 
Whilst this was not as comprehensive as some previous categorisations, it included the 
features central to our focus on the importance of the cited paper to the citing author. The 
application of this template resulted in the range of information described in Chapter Three. 
 
In parallel to the first two elements, we wished to trial a more formal qualitative approach to 
understand the processes by which the body of research influenced subsequent work, 
indirectly facilitated applied research, and perhaps contributed to an applied impact. It was 
hoped this would add qualitative understanding to the first two elements of the work. Chapter 
Four describes this qualitative approach. A combination of critical pathway analysis by 
experts in the research area and qualitative methods of questionnaires and interviews were 
used. The interviewing and the subsequent analysis adopted the triangulation techniques of 
building on the data from various methods and sources and comparing accounts. 
 
It was recognised from the outset that it would be extremely difficult to identify the impact of 
one set of papers from a short time period.  Furthermore, the preliminary study would be 
more complex and resource intensive than any eventual large-scale study because a range 
of methodological tools had to be developed and tested.  As it turned out, the study was 
even more complex, but also potentially more instructive, than originally envisaged as issues 
were addressed that had not been in the original plan. Some of these arose from the advice 
of the project’s Advisory Group whose membership is listed in the acknowledgements. 
Others resulted from the extremely rich and varied nature of the body of work examined. 
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Alberti, more than many researchers, believes in interaction between basic and clinical 
research. As he told us when interviewed: ‘you raise questions in humans you can’t answer; 
you go to the animals to try to answer them; you go back to the humans to confirm and 
develop them...yin and yang’. This approach, together with the many and diverse 
collaborations in which Alberti was involved, meant that the study was less able than 
anticipated to focus on following one clear strand of work, but made more progress in 
identifying clinical impact. Such impact, however, could not neatly be associated with one 
year’s work. Alberti, therefore, made various helpful suggestions which whilst they could not 
be substantially followed up in the first two elements were partially brought into the 
qualitative analysis.  
 
The final chapter builds on the previous ones to draw out the implications as to how further 
work could be conducted in the large-scale study, and to make proposals for that study. 
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2 BIBLIOMETRIC ANALYSIS 
 
2.1 Introduction 
This chapter presents the results of a bibliometric analysis, using the Science Citation Index 
(SCI) of the Institute for Scientific Information (ISI), of the data gathered about the three 
generations of papers starting with Alberti’s output from 1981 as the 1st generation.  
Information relating to all three generations mapped in the study have been analysed and 
compared. Factors covered include Research Levels, numbers of authors, their addresses, 
and numbers of addresses.  For the 1st generation publications the analysis also includes 
half-lives and funding sources. The methods used are standardised and the results will be 
compared with previous studies in the field of biomedicine. 
 
2.2 Methods 
2.2.1 Citation tracing and mapping 
The output of Alberti from 1981 was obtained from the SCI.  The 1981 SCI CD-ROM version 
was searched for publications from ALBERTI K* with Newcastle in the address field.  This 
constituted the 1st generation output and consisted of 49 publications in total; 22 meetings 
abstracts, 1 letter and 26 articles. Standard bibliometric analyses use only papers classified 
by the SCI as either articles, notes or reviews.  On consultation with Philip Home, we 
realised that three papers were missing from the SCI–generated list, all from the journal 
Diabetes Care.  The details of these articles were available from MEDLINE and therefore 
added to our database of 1st generation publications.  The 1st generation output was stored 
on an Excel worksheet, with each paper given a unique identifying code (Table 1).  Papers 
A1-A26 are recorded in alphabetical order by journal, and papers A27-A29 represent the 
additional Diabetes Care papers added subsequent to the SCI search.  When the Research 
Outputs Database (ROD) filter DIABE, which is designed to identify papers relating to 
diabetes, was applied to the 1st generation papers, eight of them (A2, A3, A9, A10, A11, 
A19, A20, A25) were assessed as not being diabetes-related.  However, on further 
examination, four (A2, A3, A10 and A25) were clearly diabetes-related and at least one of 
them (A3) was viewed by one of the co-authors as being important in later research.  This 
highlights the difficulty of using a bibliometric tool such as a subject filter in a small-scale 
study. We therefore took the whole 29 papers from Alberti in 1981 as the set on which to 
base analysis and comparisons. 
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Table 1: 1st generation papers 
Ref 
No 
Authors Title Journal Year Volume Pages
A1 Madsbad-S Faber-OK Binder-
C Alberti-KGMM  Lloyd-B 
Diurnal Profiles of Intermediary Metabolites in 
Insulin-Dependent Diabetes and Their 
Relationship to Different Degrees of Residual 
B-Cell Function 
ACTA DIABETOLOGICA 
LATINA 
1981 Vol 18  pp 115-121 
A2 Burrin-JM Worth-R Law-S 
Alberti-KGMM   
Simple Filter-Paper Method for Home 
Monitoring of Blood-Glucose, Lactate, and 3-
Hydroxybutyrate 
ANNALS OF CLINICAL 
BIOCHEMISTRY 
1981 Vol 18  pp 243-247 
A3 Conlon-JM Whittaker-J 
Hammond-V Alberti-KGMM   
Metabolism of Somatostatin and Its Analogs 
by the Liver 
BIOCHIMICA ET BIOPHYSICA 
ACTA 
1981 Vol 677  pp 234-242 
A4 Whittaker-J Hammond-VA 
Alberti-KGMM  
Effects of Colchicine on Insulin Binding to 
Isolated Rat Hepatocytes 
BIOCHEMICAL AND 
BIOPHYSICAL RESEARCH 
COMMUNICATIONS 
1981 Vol 103  pp 1100-1106 
A5 Gill-GV Sherif-IH Alberti-
KGMM 
Management of Diabetes During Open-Heart 
Surgery 
BRITISH JOURNAL OF 
SURGERY 
1981 Vol 68  pp 171-172 
A6 Barnett-AH Spiliopoulos-AJ 
Pyke-DA Stubbs-WA  Burrin-J 
Alberti-KGMM    
Metabolic Studies in Unaffected Co-Twins of 
Non-Insulin-Dependent Diabetics 
BRITISH MEDICAL JOURNAL 1981 Vol 282  pp 1656-1658 
A7 Owens-DR Jones-MK Hayes-
TM  Heding-LG Alberti-KGMM 
Home-PD Burrin-JM 
Newcombe-RG 
Human Insulin - Study of Safety and Efficacy 
in Man 
BRITISH MEDICAL JOURNAL 1981 Vol 282  pp 1264-1266 
A8 Pickup-JC Home-PD Bilous-
RW Keen-H Alberti-KGMM    
Management of Severely Brittle Diabetes by 
Continuous Subcutaneous and Intramuscular 
Insulin Infusions - Evidence for a Defect in 
Subcutaneous Insulin Absorption 
BRITISH MEDICAL JOURNAL 1981 Vol 282  pp 347-350 
A9 Mcculloch-AJ Johnston-DG 
Burrin-JM Hodson-AW Clark-F 
Waugh-C Orskov-H Alberti-
KGMM      
Diurnal Hormone-Metabolite Profiles in 
Hypothyroidism 
CLINICAL ENDOCRINOLOGY 1981 Vol 15  pp 607-619 
A10 Blesa-Malpica-G Johnston-DG 
Burrin-JM Orskov-H Heath-AB 
Alberti-KGMM     
Dopaminergic Control of Ketogenesis in 
Fasting 
CLINICAL ENDOCRINOLOGY 1981 Vol 14  pp 479-484 
A11 Harvey-JE Baldwin-CJ Wood-
PJ Alberti-KGMM  Tattersfield-
AE  
Airway and Metabolic Responsiveness to 
Intravenous Salbutamol in Asthma - Effect of 
Regular Inhaled Salbutamol 
CLINICAL SCIENCE 1981 Vol 60  pp 579-585 
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Ref 
No 
Authors TitleWhen the Journal Year Volume Pages
A12 Massi-Benedetti-M Noy-G 
Johnston-IDA Worth-R Alberti-
KGMM    
Glucose Controlled Insulin Infusion System 
(Biostator) Application During Surgery for a 
Presumed Pancreatic Micro-Insulinoma 
DIABETE & METABOLISME 1981 Vol 7  pp 41-44 
A13 Jenkins-DJA Taylor-RH Goff-
DV Fielden-H Misiewicz-JJ 
Sarson-DL Bloom-SR Alberti-
KGMM       
Scope and Specificity of Acarbose in Slowing 
Carbohydrate-Absorption in Man 
DIABETES 1981 Vol 30  pp 951-954 
A14 Nosadini-R Noy-G  Kurtz-AB 
Alberti-KGMM  
Differential Response to Infusions of Highly 
Purified and Conventional Bovine and Porcine 
Insulins 
DIABETES 1981 Vol 30  pp 650-655 
A15 Whittaker-J Cuthbert-C 
Hammond-V Alberti-KGMM   
Impaired Insulin Binding to Isolated 
Adipocytes in Experimental Diabetic-
Ketoacidosis 
DIABETOLOGIA 1981 Vol 21  pp 563-568 
A16 Andrews-WJ Henry-RW 
Alberti-KGMM Buchanan-KD  
The Gastroenteropancreatic Hormone 
Response to Fasting in Obesity 
DIABETOLOGIA 1981 Vol 21  pp 440-445 
A17 Nosadini-R Noy-GA  Alberti-
KGMM Hodson-A  Orskov-H 
The Metabolic Response to Hyperglycemic 
Clamping in Insulin-Dependent Diabetes 
DIABETOLOGIA 1981 Vol 20  pp 113-117 
A18 Metcalfe-P Johnston-DG  
Nosadini-R Orksov-H Alberti-
KGMM   
Metabolic Effects of Acute and Prolonged 
Growth-Hormone Excess in Normal and 
Insulin-Deficient Man 
DIABETOLOGIA 1981 Vol 20  pp 123-128 
A19 Hanson-RD Gray-RM Alberti-
KGMM  
Liver Metabolites in Resting and Exercising 
Rats at 1-Bar and 4-Bar 
JOURNAL OF APPLIED 
PHYSIOLOGY 
1981 Vol 51  pp 1326-1330 
A20 Twentyman-OP Disley-A 
Gribbin-HR  Alberti-KGMM 
Tattersfield-AE   
Effect of Beta-Adrenergic-Blockade on 
Respiratory and Metabolic Responses to 
Exercise 
JOURNAL OF APPLIED 
PHYSIOLOGY 
1981 Vol 51  pp 788-793 
A21 Schmitz-O Alberti-KGMM 
Hreidarsson-AB Laurberg-P 
Weeke-J Orskov-H  
Suppression of the Night Increase in Serum 
TSH During Development of Ketosis in 
Diabetic-Patients 
JOURNAL OF 
ENDOCRINOLOGICAL 
INVESTIGATION 
1981 Vol 4  pp 403-407 
A22 Owens-DR Jones-MK Hayes-
TM Heding-LG Alberti-KGMM 
Home-PD Burrin-JM     
Comparative-Study of Subcutaneous, 
Intramuscular, and Intravenous Administration 
of Human Insulin 
LANCET 1981 Vol 2  pp 118-122 
A23 Desilva-NE Tunbridge-WMG 
Alberti-KGMM  
Low Incidence of Chlorpropamide-Alcohol 
Flushing in Diet-Treated, Non-Insulin-
Dependent Diabetes 
LANCET 1981 Vol 1  pp 128-131 
A24 Stevenson-RW  Parsons-JA  
Alberti-KGMM 
Comparison of the Metabolic Responses to 
Portal and Peripheral Infusions of Insulin in 
Diabetic Dogs 
METABOLISM-CLINICAL AND 
EXPERIMENTAL 
1981 Vol 30  pp 745-752 
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Ref 
No 
Authors Title Journal Year Volume Pages
A25 Nosadini-R Alberti-KGMM 
Johnston-DG Del Prato-S 
Marescotti-C Duner-E   
The Anti-Ketogenic Effect of Alanine in Normal 
Man - Evidence for an Alanine-Ketone Body 
Cycle 
METABOLISM-CLINICAL AND 
EXPERIMENTAL 
1981 Vol 30  pp 563-567 
A26 Home-PD Pickup-JC Keen-H 
Alberti-KGMM Parsons-JA 
Binder-C    
Continuous Subcutaneous Insulin Infusion - 
Comparison of Plasma-Insulin Profiles After 
Infusion or Bolus Injection of the Mealtime 
Dose 
METABOLISM-CLINICAL AND 
EXPERIMENTAL 
1981 Vol 30  pp 439-442 
A27 Massi-Benedetti-M Burrin-JM 
Capaldo-B Alberti-KGMM    
A Comparative Study of the Activity of 
Biosynthetic Human Insulin and Pork Insulin 
Using the Glucose Clamp Technique in 
Normal Subjects 
DIABETES CARE 1981 Vol 4  pp 163-167 
A28 Taylor-R Home-PD Alberti-
KGMM   
Plasma Free Insulin Profiles After 
Administration of Insulin by Jet and 
Conventional Syringe Injection 
DIABETES CARE 1981 Vol 4  pp 377-379 
A29 Worth-R Harrison-K Anderson-
J Johnston-DG Alberti-KGMM    
A  Comparative Study of Blood Glucose Test 
Strips 
DIABETES CARE 1981 Vol 4  pp 407-411 
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The SCI was searched from 1981 to June 2001 for the papers that cited the 29 1st generation 
papers, and thus constituted our 2nd generation output.  The format for the search was as 
follows3: 
1st author-year-*-vol-1st page number  
eg FRAME-IA-1983-*-V34-P51 
* is a wild-card entry to catch all journals recorded with the SCI. 
 
In addition to identifying the numbers of citations in each generation, the relationships between  
papers in the generations were also mapped. In all, there were 848 2nd generation publications of 
which 799 were classified as articles notes and reviews. (The remainder were items such as 
letters). The 2nd generation articles, notes and reviews were given an identifying number and 
linked directly to the 1st generation paper(s) that they cited.  As a result of some 2nd generation 
publications citing more than one 1st generation paper, the number of unique 2nd generation 
papers was lower at some 730. The details of these unique 2nd generation publications were 
used to search the SCI CD-ROM database (1981–June 2001) for 3rd generation papers ie. those 
papers citing the 2nd generation papers.  This resulted in a total of 13,542 3rd generation papers 
of which 12,891 were classified as articles, notes or reviews (comprising 9,376 unique papers).  
Four hundred and seventy-four of these 3rd generation papers were also 2nd generation 
publications. 
 
2.2.2 Research Levels 
Research Level values for many journals have been determined by CHI Research Inc (Narin et 
al, 1976). The system is based on expert opinion and journal-to-journal citations.  Journals are 
allocated into four hierarchical levels in which each level is more likely to cite papers in journals 
at the same level or the level below and vice versa (Table 2). 
 
                                                          
3 This format failed to give any information about paper A29 which appeared to have no citations and the 
format was altered to include Diabetes Care in place of the *.  This yielded 28 papers, of which 24 were 
articles, notes or reviews.  This is an important point to note regarding the search strategy and may have 
led to some citations of other papers being missed. 
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Table 2:  Definition of research levels  
Research Level Type Example 
1 Clinical observation British Medical Journal 
2 Clinical mix New England Journal of 
Medicine 
3 Clinical investigation Immunology 
4 Basic research Nature 
N/A or 0 Yet to be classified/difficult to classify - 
 
 
According to the CHI Research definitions only 4% of papers in Research Level (RL) 1, ie clinical 
observation journals (eg British Medical Journal) will cite papers in RL4, basic journals (eg 
Nature), compared to 8% for RL2 clinical mix journals, (eg New England Journal of Medicine), 
and 21% for RL3 clinical investigation journals (eg Immunology). (Wellcome Trust/NHS 
Executive, 2001). 
 
The Research Level, in theory, provides us with a transparent, systematic and generally 
accepted method of identifying basic research.  However, there are two caveats. This method of 
categorisation assumes that: 1) Research Levels have remained constant over time (20 years in 
the case of this study); and 2) all papers published within a journal are of the same Research 
Level. 
 
2.3 Results 
2.3.1 Number of papers and self-citations 
The total number of citations per year in the 2nd generation is shown in Figure 1.  The peak of the 
2nd generation papers occurs in 1983, two years after the publication of the original articles and 
then falls gradually until 2001.  The number of citations in the 3rd generation, per year, is shown 
in Figure 2. The number of papers rises steeply from 1983 through to 1987 where there is a short 
dip.  This is followed by a second rise through to 1993.  Interestingly, there is a ten-year gap 
between the peaks in each generation.  
  12 
 
 
 
 
The number of citations for each of the 1st generation papers (articles, notes and reviews only) is 
shown in Figure 3.  Two papers (A13 and A20) were cited on more than 70 occasions (76 and 74 
times respectively).  Sixteen papers were cited between 10 and 52 times with the remaining 
papers cited less than 10 times during the 20-year period. There were 623 2nd generation papers 
for which we have recorded information.  Of those papers 114 were self-citations where one or 
more of the authors of the 2nd generation publication was named on the cited paper. The number 
of citations given to each of the 2nd generation papers ranged from none to 469. 
Figure 1: Number of 2nd generation papers per year
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Figure 2: Number of 3rd generation papers per year 
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2.3.2 Half-lives 
 
Generally, a research article is born, matures in use, produces new information, loses value, 
becomes obsolete and eventually dies (Pemberton and Nugent, 1995).  The measure of a journal 
article’s half-life is therefore a rather crude measure of its value and obsolescence.  Half-life is 
measured by the time it takes for an article to receive 50% of its citations.  The half-lives of the 29 
1st generation papers are shown in Figure 4. 
Figure 4: Half-lives of 1st generation papers
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Figure 3: Citations of 1st generation papers 
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The half-life for the 29 1st generation articles taken as a group was five years and the half-life for 
the 2nd to 3rd generation output was seven years. 
 
2.3.3 Research Levels 
The Research Level (RL) of the papers in each of the three generations is shown in Figure 5.  
The RLs, as noted on Table 2, go from clinical observation (RL1) to basic research (RL4), but no 
Research Level had been allocated to a small number of the journals. There is a broad similarity 
in the proportion of papers within each Research Level between generations, with no apparent 
shift, as might have been expected, from RL4 to RL1.  These papers are slightly more clinically 
oriented than the proportions published previously for all diabetes research in England: 13% RL1, 
18% RL2, 42% RL3 and 22% RL4. (Wellcome Trust/NHS, 2001). 
 
 
When only RL4 papers (basic research) from the 1st generation were analysed, the distribution of 
Research Levels of the papers citing them in the 2nd and 3rd generations was different from the 
overall picture: there were proportionately more RL4 papers and fewer RL1 papers (Figure 6).  
 
 
 
 
Figure 5: Research Levels of 1st, 2nd and 3rd generation papers 
3 8 6 
24 18 16 
14 
23
22 
45 
38
39 
17 14 13
0% 
10% 
20% 
30% 
40% 
50% 
60% 
70% 
80% 
90% 
100% 
1st  2nd 3rd  
Generation
Pr
op
or
tio
n 
 
RL4
RL3
RL2
RL1
RL0
  15 
 
Similarly, when only RL1 papers from the 1st generation were used to define subsequent 
generation outputs, the papers remained within the clinical (RL1 and RL2) journals (Figure 7).  
This finding supports the basis of the CHI Inc Research Level system where papers in journals of 
a given Research Level are more likely to cite papers in journals at the same level or the level 
below and vice versa. 
 
 
 
 
Figure 6:  2nd & 3rd generation RLs from RL4 1st generation papers 
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Figure 7:  2nd & 3rd generation RLs from RL1 1st generation papers 
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2.3.4 Number of authors and addresses 
The proportion of papers with different numbers of authors between the three generations is 
shown in Figure 8.  None of the 1st generation papers had less than 3 authors, with 17 of 29 of 
the papers having five or more authors, much higher than in subsequent generations. This 
appears to indicate that Alberti was collaborating with a large number of people and/or that he 
had a large active research group at that time. Recent figures show a national average in 
biomedical research of 3.8 authors per paper (The Wellcome Trust, 1998). They also show, 
however, that between 1988 and 1995 the percentage of papers published in the UK with over 5 
authors gradually increased, indicating that there was an increasing level of collaboration 
between biomedical researchers.  The average number of authors per paper in diabetes 
research in England between 1990 and 1997 was just over five (The Wellcome Trust/NHS, 
2001). 
 
 
Table 3 summarises the median and mean numbers of authors for all papers in each of the three 
generations.  The median number of authors is slightly higher for the 1st generation papers than 
either of the subsequent generations as is the mean.  
 
Table 3: Mean and median number of authors for each of the three generations 
 1st generation 2nd generation 3rd generation 
Mean ± sd 5.0 ± 1.6 4.1 ± 2.4 4.3 ± 5.3 
Median 5 4 4 
 
 
Figure 8: Proportion of papers with different numbers of authors in all 3 generations 
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The number of addresses per paper is an indication of collaboration between different research 
groups.  The numbers of addresses per paper for all three generations are shown in Figure 9. 
 
 
 
There are 28% of 1st generation papers with a single address, approximately half of those in 
subsequent generations (45% 2nd generation and 44% 3rd generation).  The proportion of UK 
biomedical research papers in 1995 bearing single addresses was 44.3% (The Wellcome Trust, 
1998).  There are 14% of 1st generation papers with four addresses, which is, approximately, 
double those in subsequent generations (6% generation 2 and 7% generation 3).  This suggests 
that Alberti’s group was collaborating with other research groups at this time.  The UK national 
average number of addresses per paper was 2.0 in 1995. 
 
2.3.5 Authors’ addresses by country and distribution in the UK 
Figure 10 shows the proportion of papers in each of the three generations from different 
countries.  The main point to note here is that 2nd generation publications continue to have a 
proportionately high level of UK addresses compared to the USA.  However, by the 3rd 
generation, the number of UK addresses has fallen in comparison with the USA although it 
remains higher than the other countries examined. 
 
 
 
 
 
Figure 9: Proportion of papers with different numbers of addresses in all 3 generations 
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The distribution of all UK addresses for all three generations was examined. It indicates that in 
the first generation there was some residual output from Alberti’s time spent at Southampton, in 
addition to ongoing collaborative research at Cardiff, Oxford and London.  In the 2nd generation 
papers the proportion of Newcastle addresses remains high, presumably through the effect of 
self-citation, although of course a wider range of centres also feature.  By the 3rd generation the 
influence has spread throughout the UK, but Newcastle, Oxford, London and Nottingham emerge 
as the centres with the highest output of papers containing citations to the 2nd generation papers. 
 
2.3.6 Funding sources 
The funding sources acknowledged in the 1st generation papers were examined and 20 of the 29 
papers acknowledged financial support from the British Diabetic Association (Table 4), which 
provided core support for Alberti’s group at that time.  The Wellcome Trust and the UK Medical 
Research Council (MRC) were acknowledged on five and four papers respectively, with four of 
the 29 papers not known to have specific financial support.  The actual financial input from each 
of those sources is not recorded here, but seventeen of the papers acknowledged two or more 
sources of support and details of the funding for each paper are given in Appendix 1. 
 
 
  
 
Figure 10: Proportion of papers in each generation by country of 1st author
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Table 4: Funding sources acknowledged and/or identified for 1st generation papers 
Funding Sources Number of papers 
British Diabetic Association 20 
Novo Industries, Denmark 8 
Wellcome Trust 5 
Medical Research Council 4 
British Council 2 
British Insulin Manufacturers 2 
Newcastle Area Health Authority 2 
Newcastle Area Health Authority (Teaching) 2 
Bayer UK 1 
Danish Medical Research Council 1 
Eli Lilly 1 
Medistron Ltd and Boehringer Corporation Ltd [for the 
modified Glucocheck meter] 
1 
Minet Trust 1 
National Institutes for Health 1 
Northern Regional Health Authority 1 
Pfizer Ltd [materials] 1 
Royal Victoria Hospital Belfast Research Fellowship 1 
Servier Laboratories 1 
Synthelabo (Paris) 1 
None 4 
 
 
2.4 Key findings 
2.4.1 Key observations about the body of work 
The average number of citations to the 1st generation papers was higher than anticipated in our 
project application.  This probably reflects the importance of Alberti’s portfolio of work plus the 
fact that diabetes journals have one of the highest average impact factor scores (Wellcome 
Trust/NHS Executive, 2001).  Within the high overall average, there was considerable variation in 
the number of citations.  Similarly, the half-lives showed a wide range. 
 
The Research Level of papers demonstrated the breadth of Alberti’s work -- the 29 articles were 
spread across all four Research Levels.  Crucially, there was not a shift from basic to more 
clinical levels across the generations.  The information about the higher than average number of 
authors and addresses per paper is again testimony to the extent of Alberti’s collaborations.  The 
analysis of the nationality of the addresses shows, firstly, that Alberti was collaborating 
internationally and, secondly, how far the work spread into the international literature in the 2nd 
and 3rd generations.  By the 3rd generation, the publications more accurately reflected the 
international pattern of research output. 
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From the funding acknowledgements, the most striking observation is the high proportion of 
papers supported, at least partially, by the British Diabetic Association (BDA).  
 
2.4.2 Key lessons learnt about how to conduct such an exercise 
The application of a range of standard bibliometric techniques produced a considerable body of 
information. This type of analysis, however, becomes very time-consuming when the number of 
papers and citations becomes as large as happened here.  
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3 CATEGORISATION OF CITATIONS 
3.1 Introduction 
Chapter 2 presented results of a bibliometric analysis of the papers in this preliminary study.  
This Chapter is concerned with a detailed analysis of the citations. We start by describing a 
review of previous literature in this field. This was drawn on to devise an assessment/appraisal 
template to be applied to the 2nd generation papers. The template captured information relating to 
each occasion the 1st generation paper was cited in the paper, including its location and whether 
it was applying, supporting, developing or refuting a method or concept in the cited article or 
whether it was merely noting or reviewing it. The class of the article, whether it was basic or 
clinical, was recorded and an assessment made of the overall importance of the cited article to 
the citing article.   
 
3.2 Literature review: Categorising citations 
This review highlights both items and procedures included in previous studies of citations, and 
their implications for our own citation categorisation. The most thorough previous general reviews 
have been those by Case and Higgins (2000), McCain and Turner (1989), Cronin (1984) and 
Small (1982).  Small, and later Vinkler (1988), also usefully compared the various classification 
schemes previously used. Small (1982, p.300) suggested that ‘by and large, the development of 
citation classification schemes has not been a cumulative endeavour’.  He went on to claim, 
however, that on closer inspection ‘there are striking parallels between the schemes proposed, 
even though the terminology used to describe the categories can differ’.  These similarities 
enabled him to devise his comparative tables. Work in this field is viewed as being quite complex 
with Case and Higgins (2000) referring to ‘epistemological and methodological problems’ (p.636) 
and Cronin (1984) suggesting ‘the process is not amenable to scrutiny’ (p.57).  
 
The main purpose of our study, to assess the impact of basic or early clinical research through 
several generations of citations, is rather different from those of most earlier studies.  Therefore, 
although we drew lessons from previous work, we needed to use it in a way that helped with our 
specific aim to use citation content/context analysis, in combination with citations tracing through 
several generations, to assess the payback from basic/early clinical research. 
 
Following this introduction to the literature review, there are sub-sections on:  
• the aims of analysing citations;  
• procedural issues: who undertakes the classification of citations and to which citations is it 
applied?;  
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• what to include in a classification: motives/reasons for citing and strength of impact on the 
citing paper;  
• the location and frequency of citations  within an article; 
• combining the factors. 
 
3.2.1 The aims of analysing citations 
The wider analysis of citations is undertaken for many reasons.  Here we identify some of those 
most relevant for our project.  Small (1982) concluded that citation context analysis is pursued by 
two groups: ‘those concerned with information retrieval, and those concerned with the sociology 
of science and citation analysis’ (p.308).  The first stream of work, according to Small, started 
with Lipetz (1965) who wanted to improve information retrieval from citation indexes by devising 
a scheme of categories which an indexer would apply to each reference in a citing document.  
This stream of work proved to be impractical although Small (1982) and Cronin (1984) described 
various attempts to build on Lipetz’s work: Finney (1979); Duncan et al, (1981).  The importance 
of this work for us is that it describes attempts to move towards more routine approaches that we 
also see as being our ultimate goal.   
 
The stream of work associated with the sociology of science started, according to Small, with a 
study by Moravcsik and Murugesan (1975).  This has been the more productive stream. 
Moravcsik and Murugesan (1979) applied their previously developed method of classifying 
citations in scientific papers (1975) to studying two scientific revolutions in theoretical physics.  
.Although concerned, like our project, with the development of science, their main interest was to 
analyse citations in order to understand ‘paradigm changes’ (Kuhn, 1970) rather than trace the 
impact of a certain body of work. Various other studies in this stream were motivated by a 
concern to assess the adequacy of citation counts as a measure of scientific impact 
(Small,1982).  Perhaps the analysis nearest to our concerns comes from studies that attempt to 
examine how citation patterns to certain highly cited papers might have varied over time 
(Cozzens, 1985; Oppenheim and Renn 1978; McCain and Turner, 1989). The latter took 11 
highly cited papers in molecular genetics written between 1978-80.  These 11 received a total of 
3100 citations. Although for each of the 11 papers, they analysed only 10 citations in articles 
published in years one and two, and 10 in years six and seven, their approach was important and 
is further analysed in a later section. 
 
Attempts to explain the nature of citations as either ‘concept symbols’ (Small, 1978) or as a 
process of persuasion (Gilbert, 1977) are important background papers for our study. Gilbert 
listed various reasons why a paper might be cited by an author as part of his attempt to persuade 
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readers of the importance etc of his own article.  The author might ‘cite the “important and 
correct” papers’ (Gilbert, 1977, p.116) to add credence to his paper and might cite ‘erroneous’ 
papers to build up the importance of his advances.  Gilbert noted, however, ‘that respected 
papers may be cited to shine in their reflected glory even if they do not seem closely related to 
the substantive content of the report’ (Gilbert, 1977, p.116).  Gilbert’s analysis has gained 
considerable support (see, for example, Brooks, 1985; Allen et al, 1994; and Case and Higgins, 
2000) but highlights the difficulties in developing a template in a way that will accurately gather 
information.  These issues are part of a wider, ongoing debate about the need for a theory of 
citations (see, for example, Cronin, 1984; Leydesdorff, 1998). 
 
As noted in the introduction to the report, our proposed use of citations to track the impact of 
basic/early clinical research, through from the original papers to later work, is an approach that a 
recent major review of citations suggested was potentially useful but undeveloped (Kostoff, 
1988). Gläser and Laudel (2001) recently claimed that ‘research into establishing a typology of 
citations has ceased, and today we simply do not know how affirmative, rejective, perfunctory 
citations and the like are distributed. Consequently the knowledge accumulated by citation 
context analysis is not applied in ‘normal’ citation count-based studies’ (p. 429). They also 
advocated the combination of quantitative and qualitative approaches.  
 
3.2.2 Procedural issues: who classifies which citations? 
Here there are two overlapping dimensions by which previous studies have varied: 
i. Who applies the categorisation to the citations being analysed; 
ii. To which citations the classification is applied?   
 
i) Who undertakes the classification? 
There are probably two options as to who should apply the categorisation to the citations being 
analysed: 
• external reviewers/researchers; 
• the authors who made the citation – either through completion of a questionnaire, or by 
interview. 
 
In a series of early studies the reviewers each devised a categorisation of citations and applied it 
to a list of citations (Moravcsik and Murugesan, 1975; Chubin and Moitra, 1975; Spiegel-Rosing, 
1977). Several teams stressed the need for specialist knowledge of the field covered by the 
papers, or at least a scientific background, to be able to undertake this classification and 
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Moravcsik and Murugesan (1975) also highlighted the desirability of testing reliability by having 
more than one reviewer and then comparing results.  
 
There are obvious restrictions on the issues that an external reviewer can address.  Therefore, 
Prabha (1983), in a study of references given in a source paper, directly sent a questionnaire to 
authors to explore issues such as how many of the sources had the citer read and how many of 
the sources were viewed as essential.  Other advocates of the use of questionnaires to authors 
thought that questionnaires ‘bring us closer to an understanding of citation behaviour’ (Case and 
Higgins, 2000, p.645).  There are, however, weaknesses with using questionnaires and Chubin 
and Moitra (1975, p.426) claimed, ‘both the candour and recall of authors may be lacking, 
however, rendering such data impressionistic, selective and self-serving’. 
 
From a different perspective some authorities are critical of the use of questionnaires because 
they, too, are unlikely to discover the full range of author motives in giving citations.  Cronin 
(1984) and Shadish et al, (1995) advocated the use of in-depth interviews with authors and at 
least one such study (White and Wang, 1997) has been conducted.  As Case and Higgins note 
(2000, p.645), however, in-depth interviewing, as with questionnaires, ‘may suffer from problems 
of retrospective reasoning, recall and lack of honesty by respondents’.  Furthermore, qualitative 
interviewing requires a great deal of time and effort.  A further problem facing our study is the 
length of time since authors wrote their articles.  This is particularly a problem compared to White 
and Wang’s study, which was conducted at about the time the authors wrote their articles. 
 
ii)  To which citations is the classification applied? 
There have been three main approaches to identifying the citations to which the categorisation 
should be applied: 
• all the references in a source paper(s); 
• for many different authors, a selected reference they have made in one of their articles; 
• all (or a large selection) of the citations to the source paper(s) of interest to the study. 
 
In the first approach, source papers (equivalent to our 1st generation) are identified through 
various approaches and then the classification is applied to each reference in each paper. The 
second option is more complex.  It covers the work of Shadish et al, (1995) who identified a 
series of source papers and then randomly selected one reference from each article and sent the 
author of the article a detailed questionnaire about that one reference. We have put Bonzi and 
Snyder (1991) into this category, but they specifically examined self-citations. The third option, 
concentrating on the citations to the source article, is the one that our study will adopt: these 
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citations to the source paper occur in what we have defined as 2nd generation papers. Sometimes 
however, as with the McCain and Turner paper noted earlier, a selection of citations to the 
original source paper are taken rather than all of them. 
 
Table 5 below attempts to classify previous studies according to the options in the two sub-
sections above. It should be noted that at least one study, Chubin and Moitra (1975), started by 
examining the references in their source (1st generation) papers, and then analysed the citations 
to these papers.  This study therefore appears in two boxes in the table. 
 
Table 5: Who undertakes the classification and to what is it applied 
                                                                
 Who applies the classification 
To which citations is 
the classification 
applied 
A 
External reviewers 
B 
Authors who make the citation – 
via questionnaire or interviews 
1. 
All the references in a 
source paper(s) 
Lipetz (1965) 
Moravcsik & Murugesan (1975) 
Chubin & Moitra (1975) 
Spiegel-Rosing (1977) 
Prabha (1982) 
Brooks (1985) 
Vinkler (1987) 
Cano (1989) 
White & Wang (1997) 
2. 
For many authors a 
selected citation they 
have made 
 Bonzi and Snyder (1991) 
Shadish et al, (1995) 
3. 
All (or a large selection 
of) citations to the 
source paper 
 
Chubin & Moitra (1975) 
Cole (1977) 
Oppenheim & Renn (1978) 
Cozzens (1985) 
McCain & Turner (1989) 
Maricic et al, (1997) 
Case & Higgins (2000) 
 
 
3.2.3 What to include in a classification: motives and strength of impact 
Some authorities in the field have produced lists of why citations are given.  Garfield (1965) 
produced a list of 15 reasons and thought they were still valid 30 years later (Garfield, 1996). 
Lists such as this were designed as a result of the experience of working on, and thinking about, 
citations rather than, as in many of the empirical exercises described here, being developed for a 
specific empirical exercise. Shadish et al, (1995) decided, however, that it might not be 
appropriate to use an entirely externally generated list of reasons for citing and attempted to 
supplement the lists of previous authorities by systematically asking their own colleagues what 
had motivated them in citation behaviour.  Similarly White and Wang (1997), in their direct 
interviews with authors about the reasons behind their citation lists, allowed the reasons to 
emerge from the authors.   
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We conclude that there is now so much previous research on which to build and sufficient 
externally generated lists of reasons for citing that it is unnecessary to take the exercise one 
stage further back and ask authors to help devise yet another new list.  This conclusion is 
supported by the comments of Case and Higgins (2000) who, in their empirical study, built on the 
work of Shadish et al, (1995) and like them found that when they operationalised their research 
instrument, ‘no other distinctive reasons for citing a document were uncovered in the open-ended 
responses’ (p.639).   
 
In the previous studies there are various dimensions, and combinations, of the question about 
what to incorporate in a classification of citations. These dimensions include:  
• whether the focus is on motivations/reasons for citing, or on strength of impact the cited 
work has made on the paper citing it, or on a combination; 
• the importance of including the questions that authors would be able to answer even 
though external reviewers could not;  
• whether single or multiple motivations are linked to each citation. 
 
Given this range of dimensions on which previous studies have varied, the following account 
does not attempt to provide a neat classification but instead provides a broad framework for 
considering key contributions. Some researchers, for example Spiegel-Rosing (1977), produced 
a list of motives for citing and attempt to classify all the references into one category or another.  
In this case it was not very satisfactory because of her 13 reasons, 80% were fitted into just one 
category.  Other studies have allowed the external reviewer, or the citing author, to identify 
several motives behind each citation.  
 
Moravcsik and Murugesan’s 1975 study is seen as a key contribution.  The categorisation they 
devised and then applied had four elements and in each one they classified each citation as 
belonging to one of two alternatives (or neither): 
• Conceptual, Operational, neither 
• Organic, Perfunctory, neither 
• Evolutionary, Juxtapositional, neither 
• Confirmative, Negational, neither. 
 
Several authors started with the above classification and added variations. They include Swales 
(1986, reported in Ungern-Sternberg, 2000), and Chubin and Moitra (1975) who put references 
into one of 6 categories and attempted to add some measure of strength. Cano (1989) went back 
to the original four pairs of items and used them, but not only as a series of alternatives.  This 
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resulted in some authors making clear that both options in some pairs, for example conceptual 
and operational, were motivations for some citations. 
 
As noted earlier, Small (1982, pp.302-3) and Vinkler (1998, pp.133-4) attempted to show the 
similarities between a range of classifications previously devised by other authors.  Small took 
the work of Lipetz as the ‘Procrustean bed to which the others can be related’ (1982, p.300).  
Having attempted to show the comparisons he then devised the following list of items, which are 
not seen as mutually exclusive (p.304): 
• Refuted (negative) 
• Noted only (perfunctory) 
• Reviewed (compared) 
• Applied (used) 
• Supported (substantiated) 
 
When questionnaires (or even interviews) with authors are used, this increases the number of 
motivations that may be enquired about.  Vinkler (1987) made a distinction between 
‘professional’ motivations and ‘connectional’ ones.  The former are to do with the traditional items 
used in citation classifications such as that the citation may be: affirmative, comparative, 
perfunctory and/or negative etc.  The ‘connectional’ motivations are to do with the social 
relationship between the citing author and the author of the paper cited.  Others have used 
different terms for this category, but clearly most information about such motives can be gathered 
only directly from the authors, although some, such as whether the citing paper comes from the 
same institution as the cited paper, could be recorded by external reviewers. 
 
Brooks (1985) asked authors to assess their motives for giving each reference along seven 
scales (although he also allowed authors to add in their own motives). Shadish et al, (1995), and 
the replicatory study by Case and Higgins (2000), used a list of about 28 possible reasons for 
citing.  Authors were asked to plump for which was the most important, but then also asked to 
apply a five point Likert scale to each of the 28 reasons.  Shadish et al, (1995) also asked a 
series of ‘proximity’ questions similar to Vinkler’s connectional questions.  They covered issues 
such as ‘Have you ever spoken directly or by phone with the author of this citation?’ 
 
We have already noted that Prabha (1983) was one of the first to send questionnaires to citing 
authors.  This enabled him not only to ask questions about whether the citing authors consulted 
the cited paper whilst actually writing their papers, but also to ask a question about the strength 
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of impact.  For each paper cited, Prabha asked whether the author drew heavily, moderately or 
peripherally on the source.   
 
This type of analysis would seem to be near to what we are attempting to identify in our project. 
Cano (1989) asked authors to state which of the eight items, derived as we have seen from 
Moravcsik and Murugesan’s four pairs, was a motive behind their decision to include a reference. 
The most frequent of the eight categories was ‘perfunctory’, which was seen by Small (1985) as 
being equivalent to his term, ‘noted only’. Cano then asked authors to judge the utility content of 
each reference they had cited.  They were asked to rate on a four-point scale the level to which 
each reference had contributed to the production of the technical paper.  The utility content of a 
reference was therefore defined as ‘that which makes a reference indispensable in the 
production of novel information’ (p.285).  The four points were: peripheral, moderate, heavy and 
essential. The perfunctory references were generally seen to have low utility on this four-point 
scale.  
 
3.2.4 The location and frequency of citations within an article  
Cano (1989) recorded the position of each citation in terms of its distance (in fraction terms) from 
the start of the article.  This location question was recorded along with more detailed 
motivational/strength of impact data noted in the previous section. Other authors (especially 
McCain and Turner, 1989; and Maricic et al, 1997) gave more emphasis to the location of a 
citation in terms of the section of an article in which it appeared. This, they correctly claimed, was 
a more objective factor than distance from the start. They used categories that could be applied 
in a fairly standard way, such as: introduction, methods, results, conclusion/discussion and 
McCain and Turner (1989) assumed that a citation in a methods section of a research paper was 
worth more than one in the introduction of a paper, or in a review article. 
  
Information about the number of times an article was cited in the citing article was recorded in 
various studies (Oppenheim and Renn, 1978; McCain and Turner, 1989), with the former 
examining 978 papers that in 1974-5 cited some old highly cited papers in physics and physical 
chemistry. They found on average each paper was cited 1.13 times by each citing article. They 
noted Chubin and Moitra’s claim that on average each cited paper they examined was cited 1.05 
times by the citing article. They therefore concluded: ‘our results indicate that there is a rule that 
states that each cited paper is referred to on average 1.05-1.15 times in every paper that cites it 
and which may be valid over much of science’ (Oppenheim and Renn, 1978, p. 230). 
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3.2.5 Combining factors 
In the preceding sections various items of information have been noted as probably worth 
recording, and at least one study (McCain and Turner, 1989) showed how various items could be 
brought together. Their Utility Index ‘combined citation occurrence counts, citation location, and 
citation context in a single measure of “perceived usefulness”’ (p. 149). Their approach, however, 
was rather mechanistic, and as noted above, made assumptions about the score to give a 
citation depending on, for example, predetermined ratings for different locations, rather than 
judging each individual citation.  Furthermore, in their analysis self-citations were automatically 
given a lower score and there was a formula applied to cover, on a diminishing scale, the score 
for each time an article was cited in the citing article. 
 
The various items discussed in the literature review informed our analysis of how to develop a 
template mechanism that combined factors so as to help us identify the papers in the 2nd  
generation that viewed the 1st generation papers (ie source papers) as being important. It was 
intended that analysis of the 3rd generation would concentrate on those papers that cited 2nd 
generation papers where the citation to the source paper was seen as being important. 
 
3.3 Methods 
3.3.1 Devising the template 
The literature review above (section 3.2) informed the development of the template to be used for 
classifying each citation.  The template was intended to capture information on all of the citations 
to 1st generation source papers (A1-A29). The template differed from the mechanistic 
approaches of some previous studies. (eg McCain and Turner, 1989). Our aim was to keep the 
template to one page and have clear definitions of the terms used.  It was clear however, that in 
relation to motives two versions of the template were needed; one for articles and notes and one 
for reviews.  The template covered: 
• the location of each citation occasion (eg, for articles: Introduction, Materials & Methods, 
Results, and Discussion; for reviews: Introduction, Discussion and Elsewhere) 
• the motives, or reasons, for citing the paper (ie, for articles: Develop, Support, Apply, 
Refute, Note/Review only; for reviews: Support, Refute, Note/Review only—it is important 
to record that for articles the category ‘Develop’ was added to list from Small (1982) 
described above);  
• an overall assessment of the importance of the cited paper to the citing paper.  This 
overall assessment was based on the reviewers’ application of a scale with a definition for 
each of four levels that was very similar to that used by Cano (1989) and again described 
above (Peripheral, Moderate, Considerable and Essential); 
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• information about whether the paper described basic or clinical research. The attempt 
here was, instead of just relying on the classification of journals, to undertake the analysis 
at the level of individual papers as had been previously suggested by Mason et al (2001).   
 
Some members of the Advisory Group applied the first draft of the template to a limited selection 
of 10 papers (articles and reviews) and their comments informed changes. The final version of 
the template, including the definition of terms, is shown in Appendices 2-4 along with the 
instructions on how to use it. 
 
3.3.2 The Pilot study 
Two research assistants were employed to photocopy the relevant articles on which we planned 
to apply the template.  Only articles, notes and reviews in English were copied and review 
articles which were longer than 70 pages were not included in the study. Iain Frame, the two 
research assistants, and Philip Green and Stephen Hanney all applied the template to a selection 
of 50 2nd generation papers. Assessors 1-5 were regarded as non-experts in the field of diabetes 
although assessors 1 and 4 had a background in natural sciences. Subsequently, we also asked 
a scientist who was involved in basic diabetes research, to apply the template to the same 50 
papers.  
 
The 50 papers from the 2nd generation that were used in the pilot consisted of 41 original articles 
and 9 reviews. Of these 50 papers, 46 cited just one 1st generation paper, two of them cited three 
of our 1st generation papers, and another two both cited five 1st generation papers; thus giving a 
total of 62 examples of citing papers.  The intention was that all six assessors should apply the 
template to each of these 62 examples. The results were entered into a database and the entries 
checked by a second person. Statistical analysis of inter-rater reliability was undertaken. The 
results of this pilot study are shown in section 3.4. 
 
3.3.3 Application of the template 
The template was also applied by one assessor (IAF) to the photocopies of most of the remaining 
2nd generation papers. On-screen forms allowed direct entry of the collected data. The results 
from this main phase are described in section 3.5. 
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3.4 Results and lessons from the Pilot study 
3.4.1 Importance of the cited article to the citing article 
There is a reasonable similarity in the broad pattern of the results from the assessors analysing 
the 62 examples using the 4 categories (Peripheral, Limited, Considerable or Essential) to 
describe the overall importance of the cited article to the citing article. These are shown on 
Figure 11. 
 
There is something of a spectrum which is particularly clear if Peripheral and Limited are classed 
together as low importance and Considerable and Essential are classed together as high 
importance. Assessor 4 is at one end of the spectrum: he regarded the vast majority of the cited 
papers as either Peripheral or Limited and categorised no papers as Essential. Assessor 2 is at 
the other end of the spectrum, with an almost exactly even split between high and low 
importance. The dividing line for the each of the remaining four assessors fell within a few 
percentage points of having one quarter as high importance and the rest low. These four in the 
middle include assessor 1, the lead researcher and co-deviser of the template, assessor 5, the 
other co-deviser of the template, and assessor 6, the diabetes researcher. In the subsequent 
analysis, therefore, particular attention was given to the level of agreement between these three 
assessors. 
 
In Table 6a the overall level of agreement as to the importance of the cited article is shown, and 
then the same when the four categories are collapsed in to the two: high and low importance. For 
five of the 62 examples, however, data were not available for one or more of the assessors. 
Therefore, the analysis relates to the remaining 57 examples of 2nd generation papers citing 1st 
 Figure 11: Overall proportions of categories of importance of cited article to citing 
article as rated by six assessors 
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generation papers. An analysis of inter-rater reliability was carried out using the kappa coefficient 
(Stata Press, 1999). The kappa statistic is scaled where a value 0 denotes agreement that would 
be observed by chance, and 1 denotes perfect agreement. To interpret the kappa statistic six 
terms are used: poor (which is a score of less than zero); slight (0.00-0.20); fair (0.21-0.40); 
moderate (0.41-0.60); substantial (0.61-0.80) and almost perfect (0.81-100). The kappa statistic 
for each column is shown on Table 6a. Given the spectrum shown in Figure 11, it is perhaps not 
surprising that the level of agreement is classified as only fair, even when the categories are 
collapsed.  Table 6b reveals that the agreement is stronger for the three assessors: 1, 5 and 6. 
 
Table 6a: Agreement on importance of cited paper to citing paper: all 6 assessors 
No of assessors 
agreed 
No of agreed ratings (%) using 
all four categories of 
importance 
No of agreed ratings (%) using 
High and Low importance 
categories 
All 6 3/57 (5%) 24/57 (42%) 
5 14/57  (25%) 19/57 (33%) 
4 23/57 (40%) 10/57 (18%) 
3 13/57 (23%) 4/57 (7%) 
2 4/57 (7%) N/A 
Kappa Slight Fair 
 
 
Table 6b: Agreement on importance of cited paper to citing paper: assessors 1,5 and 6 
No of assessors 
agreed 
No of agreed ratings (%) using 
all four categories of 
importance 
No of agreed ratings (%) using 
High and Low importance 
categories 
All 3 29/57 (51%) 40/57 (70%) 
2 25/57 (44%) 17/57 (30%) 
No agreement 3/57 (5%) N/A 
Kappa Fair Moderate 
 
 
3.4.2 Categorising citations 
For each cited paper, the assessors were asked to note each occasion a citation was given to a 
citing paper. As noted above, for the detailed analysis it was important to have information from 
each assessor on a common basis. All six assessors were in total agreement on the number of 
citations for 42 of the 57 papers (74%), and for the three assessors the figure rose to 49 (89%). It 
is difficult to give a definitive explanation as to why the assessors sometimes differed on the 
number of citation occasions.  [In some cases, the poor quality of the photocopy may have 
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contributed.]  However, there was no set pattern.  Each assessor was capable of missing citation 
occasions compared to the rest of the group. For each occasion, the location of the relevant 
citation was recorded as: Introduction, Materials & Methods, Results, or Discussion in the case of 
notes and articles; or Introduction, Elsewhere, or Conclusion in the case of reviews.  
 
Quite a few of the 57 examples of all assessors analysing 1st generation papers involved the 
paper being cited on more than one occasion in the same 2nd generation paper. This gives us a 
total of over 100 citation occasions. There were various “mismatches” where one or more of the 
assessors had recorded fewer citations in different locations. But there were 70 
occasions/locations that matched between all 6 assessors and therefore the analysis 
concentrated on them. The complete analysis of the assessors’ scores was complex, involving 
the individual analysis of separate databases. The statistical analyses referred to below included 
all six assessors and data for the three assessors in several forms (but, to facilitate comparisons, 
the analysis of the responses from the three assessors was limited to the same 70 occasions 
where data were available for all six assessors). 
 
Each of the 70 examples was examined to see whether, using the definitions given in Appendix 
4, the citation had been categorised as Apply, Support, Develop, Refute, or Note/Review only. 
Again inter-assessor reliability was assessed using the kappa coefficient measure. The level of 
agreement between the assessors varied greatly over the five categories: whereas for Apply the 
agreement was almost perfect, at the other extreme it was only slight for Develop. For Support, 
Refute and Note/Review only it was fair (Table 7), but for each of these categories it was higher 
when just the three assessors were considered. Since assessor 1(IAF) was to score all available 
papers, his scores are compared separately with assessor 5 and with assessor 6.  The picture is 
complex. For both of these latter two sets of comparisons there is one example where the kappa 
classification is lower than for the comparisons between all six assessors, but, overall, both sets 
show higher kappa classifications for level of agreement than those found for all assessors.  
 
In all four sets the lowest level of agreement is in the Develop category, and this probably had 
some spillover effect into the comparatively low agreement for Support, which is the nearest 
alternative category into which citation occasions could have been classified. By contrast, the 
level of agreement for the Apply category is very high and many of the citations located in the 
Materials & Methods section of an article were in this category. 
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Table 7: Levels of agreement between assessors using kappa classifications 
Category Level of 
agreement 
between all  
six assessors 
Level of 
agreement: 
assessors 1,5 
and 6 
Level of 
agreement: 
assessor 1 and 
assessor 5 
Level of 
agreement: 
assessor 1  
and assessor 6 
Apply Almost perfect Almost perfect Almost perfect Substantial 
Support Fair Moderate Fair Moderate 
Develop Slight Slight Poor Slight 
Refute Fair Substantial Almost perfect Substantial 
Note/Review 
only 
Fair Moderate Substantial Moderate 
 
 
3.4.3 Lessons from the pilots 
The analysis above suggests that it was reasonable, within the limited resources available for the 
pilot study, for assessor 1 to conduct the application of the template to the remaining papers. 
There are, however, lessons from the pilots that suggest further preliminary work should be 
conducted to increase common understanding of the various categorisations applied, and thus 
improve inter-assessor reliability, before we move on to any large-scale study. These could take 
various forms.  
 
First, attention needs to be given to the definitions of the various categories to enhance agreed 
interpretation. This could be assisted by an attempt to state how the various types of 
categorisations should be combined. There were situations, for example, where some assessors 
were categorising occasions as being Develop or Support and yet describing the cited paper as 
having only Peripheral importance to the cited paper. These would appear to be unlikely 
combinations. A somewhat more mechanistic approach towards identifying the possible 
combinations most likely to be accurate should help address this problem, as should clearer 
definitions. 
 
Second, it seems that the greatest difficulty in terms of categorising the citation occasions came 
with the category that the team added to the existing lists, namely Develop. Perhaps this 
category should not be used in future. Finally, there is clearly a need for all of those applying the 
template to meet after applying it on a few occasions and work through together their various 
interpretations of the definitions and attempt to reach a consensus about how to apply them. 
 
  35 
3.5 Results of the expanded template application to all 2nd generation articles 
3.5.1 Overall importance of the cited article to the citing article 
In total, 623 out of 799 citations to the 29 1st generation papers were scored by assessor 1 using 
the template. The results for the assessment of overall importance of the cited article to the citing 
article are shown in Table 8. For the majority of articles (351;56%) the 1st generation papers that 
they cited were assessed to be of Limited overall importance, and for a further 219 (35%) the 1st 
generation papers were classified as being of Peripheral overall importance. Only for 5 (1%) 
papers were 1st generation articles classified as being of Essential importance, with a further 48 
(8%) classified as Considerable.  
  
The median year of publication of the 2nd generation citing articles (and range) is also shown on 
Table 8 and suggests that the importance of the cited to the citing article becomes less with time. 
This finding is important in its own right. It also helps to explain why the proportion of papers in 
the two categories (Considerable and Essential) that can be collapsed to produce the high 
importance category is much lower in the overall analysis than it was at the pilot stage for 
assessor 1. As described above, the pilot stage concentrated on early papers from the 2nd 
generation where, as it has turned out, there was most likelihood of finding papers of high 
importance. 
 
Table 8: Scores of overall importance of the cited article to the citing article with median 
publication year and range of citing articles 
Overall Importance Number (%) Median publication year (range) 
Peripheral 219 (35) 1988 (1981-2001) 
Limited 351 (56) 1986 (1981-1999) 
Considerable 48 (8) 1984 (1982-1995) 
Essential 5 (1) 1983 (1982-1987) 
 
Notwithstanding that the numbers of citations had become so large that it was impossible to use 
citation categorisation to trace significant impact through several generations, it was thought 
important to attempt to explore what use could be made of the effort that had gone into 
categorising the 2nd generation. (A very small amount of categorisation of the 3rd generation was 
possible, but this is not reported here). Table 9 shows, for each 1st generation pape, the numbers 
(and proportions) of 2nd generation papers that were classified as being in each of the four 
categories of importance. 
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Data from Table 9 can be analysed in various ways. At an overall level statistical analysis was 
undertaken to see whether there was a correlation between papers that were highly cited and the 
proportion of those 2nd generation papers in which the 1st generation paper was viewed as being 
of high importance to the citing paper. For this analysis the two collapsed categories of high and 
low importance were used. A 2χ test was performed in order to establish whether there was a 
relationship between the number of times an article was cited and the proportion of citations of 
high importance. This showed there was no significant difference across articles: 5.31228 =χ , p = 
0.295. There was no evidence of correlation between the proportion of high importance papers 
and the total number of citations ρ = 0.098. The analysis was repeated, with similar results, after 
the removal of self-citations and also of papers with first less than five citations, and then less 
than ten. 
 
Table 9: Number of times article is cited by level of importance 
 
Paper Peripheral Limited Considerable Essential Total papers scored  
(and total number of  
citing papers etc) 
A1 2 (33%) 3 (50%) 1 (17%) 0 6 (9) 
A2 2 (22%) 4 (44%) 3 (33%) 0 9 (9) 
A3 18 (44%) 20 (49%) 3 (7%) 0 41 (47) 
A4 3 (33%) 6 (66%) 0 (0%) 0 9 (13) 
A5 2 (33%) 3 (50%) 1 (17%) 0 6 (10) 
A6 19 (48%) 20 (50%) 1 (2%) 0 40 (47) 
A7 10 (33%) 17 (52%) 6 (18%) 0 33 (42) 
A8 9 (28%) 19 (59%) 3 (8%) 1 (4%) 32 (44) 
A9 1 (50%) 1 (50%) 0 (0%) 0 2 (3) 
A10 2 (40%) 3 (60% 0 (0%) 0 5 (6) 
A11 20 (53%) 17 (45%) 1 (3%) 0 38 (46)  
A12 0 (0%) 1 (100%) 0 (0%) 0 1 (1) 
A13 14 (25%) 38 (69%) 3 (5%) 0 55 (76) 
A14 0 (0%) 6 (100%) 0 (0%) 0 6 (8) 
A15 4 (31%) 9 (69%) 0 (0%) 0 13 (18) 
A16 6 (46%) 5 (38% 2 (15%) 0 13 (14) 
A17 0 (0%) 6 (100%) 0 (0%) 0 6 (8) 
A18 21 (45%) 23 (49%) 3 (6%) 0 47 (52) 
A19      1 (100%) 0 (0%) 0 (0%) 0 1 (1) 
A20 12 (23%) 34 (64%) 5 (10%) 2 (4%) 53 (74) 
A21 3 (50%) 2 (33%) 1 (17%) 0 6 (9) 
A22 6 (27%) 15 (68%) 1 ( 5%) 0 22 (27) 
A23 8 (32%) 15 (60%) 1 (4%) 1 (4%) 25 (32) 
A24 12 (38%) 17 (53%) 2 (6%) 1 (3%) 32 (37) 
A25 9 (60%) 6 (40%) 0 (0%) 0 15 (24) 
A26 14 (48%) 12 (41%) 3 (10%) 0 29 (39) 
A27 6 (19%) 20 (62%) 6 (19%) 0 32 (41) 
A28 11 (41%) 15 ((56%) 1 (4%) 0 27 (38) 
A29 4 (21%) 14 (74%) 1 (5%) 0 19 (24) 
Total 219 (35%) 351 (56%) 48 (8%) 5 (1%) 623 (799) 
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Of the 623 papers that were categorised 114 (18%) were self-citations. This is consistent with a 
study of over 45,000 publications in Norway in which Aksnes (2003) found that 17% of citations 
received by papers in clinical medicine were self-citations and for molecular biology and genetics 
the figure was 22%. Although self-citations are often viewed as unacceptable in evaluations, it is 
argued by Pichappan and Saravady (2002) that their role deserves further analysis. They list 
various reasons why authors give self-citations including factors, such as increasing the visibility 
of earlier work, that could be viewed as being important activities for our attempts to trace impact.  
 
Further analysis was conducted of our data-set to see whether there was a difference between 
self-citations and non self-citations in terms of the proportion of 2nd generation papers where the 
1st generation paper was viewed as being of high importance. There was a significantly higher 
proportion (20%) of self-cited articles considered to be of high importance than of non self-cited 
articles (6%) ( 41.2421 =χ , p < 0.001). Again the tests were repeated, with similar results, after 
the removal of papers with first less than five citations and then less than ten. 
 
Extending the analysis of the figures on Table 9 to consider some individual 1st generation 
papers complements various points from the overall analysis. Paper A2 has the highest 
percentage of citations viewed as being of high importance: three out of nine (33%). Two of the 
three papers of high importance, however, are self-citations. Both A14 and A17 had all their 
citations classified as being of limited importance, which means they get a score of zero for 
papers of high importance, but also zero for papers of peripheral importance. Comparisons can 
also be made between the number of citations and proportion of them viewed as being peripheral 
by the citing paper. Looking at the four papers with most citations further illustrates the lack of a 
consistent pattern. Papers A13 and A20 have 25% and 23% of citing papers classified as viewing 
the importance of the paper as peripheral. This is well below the overall average shown on Table 
9 of 35%. For the other two in the top four, A3 and A18, the figures are somewhat above the 
average at 44% and 45% respectively. This analysis will help inform the qualitative approaches 
described in the next chapter. 
 
3.5.2 Importance of the cited article and location of the citation occasion 
There were only five 2nd generation papers where the cited 1st generation paper was thought to 
be Essential, and two of the five classified the same paper as Essential. In each case, however, 
the 1st generation paper was cited on multiple occasions in the 2nd generation paper.  Thus these 
five 2nd generation papers contained 36 citation occasions, and the location of each was 
separately recorded and categorised as is shown in Appendix 5.  
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Figure 12 shows the relationship between the importance of the cited article to the citing article 
and the location of the citation occasions. The figures for Essential show how the 36 examples 
were distributed between the four locations. By contrast, there were 219 citing articles in which 
the cited paper was classified as Peripheral. Many of these citing articles would have contained 
only a single citation occasion, although some could have contained several.  
 
 
The overall pattern for each category of importance was the same, with most citation occasions 
being located in the Discussion, followed by the Introduction, Materials & Methods, and finally the 
Results. Nevertheless, there are some interesting details. Four out of the 36 citation occasions 
appearing in papers where the cited article was judged to be of Essential importance to the citing 
article occur in Materials & Methods sections. This means that, in percentage terms, the 
proportion of citation occasions appearing in the Materials & Methods section that are classified 
as being Essential are twice as high as for any other category of importance. This does not 
indicate, however, that citation occasions within a Materials & Methods location are more likely to 
be classed as Essential than anything else. Instead, it is more a reflection of the fact that, as 
shown in Appendix 5, 1st generation papers classified as Essential tend to have their multiple 
citations occurring in various parts of a citing paper, including Materials & Methods. 
 
3.5.3 Overall importance of the cited article and classification of citation 
The relationship between the overall importance of the cited article to the citing article and the 
classification of citation occasions is shown in Figure 13.  Again the column for the articles 
 
Figure 12: Location of citation vs Importance of citation 
0 
10 
20 
30 
40 
50 
60 
70 
Peripheral Limited Considerable Essential
Importance
Pr
op
or
tio
n 
(%
)  
Introduction 
Materials & Methods 
Results 
Discussion 
  39 
classified as Essential shows the categorisation proportions for the 36 citation occasions 
occurring in the five 2nd generation papers. Only papers classified as articles or notes were used  
in this analysis. 
 
 
In all four levels of importance the most frequent classifications were Note/Review only and 
Support with relatively few citation occasions classified as Apply, Develop or Refute. The most 
striking trend in the classification of citations across the four categories is the shift from a majority 
of Note/Review only citation occasions in the Peripheral articles to a majority of citation 
occasions categorised as Support in the Essential articles.  Almost 80% of citations in those 
articles deemed Peripheral were Note/Review only compared to just over 20% in those classified 
as Essential. Conversely, over 50% of citations in those papers categorised as being of Essential 
importance were classified as Support compared with less than 15% of citations in the Peripheral 
importance category. Given that the focus here is on citation occasions, it is understandable that 
there are some occasions within articles classed as Essential that are only described as 
Note/Review. It might be more surprising that there are as many as 15% of citation occasions in 
the Peripheral importance group that are classified under Support. As there are only five 2nd 
generation papers in the Essential group it is perhaps not too surprising that there are no 
occasions classified as being Develop. Nevertheless, this might cast further doubt on the 
usefulness of the Develop category. 
 
 Figure 13: Classification of citation vs overall Importance of cited article 
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3.5.4 Article class and Research Level 
The concept of assigning a Research Level to a particular Journal has been described previously 
(Chapter 2).  Individual papers within the 2nd generation were assigned to one of two categories, 
Basic or Clinical4. Comparisons of article class and Research Level are shown in Figure 14.  
Whilst the majority of papers describing basic research tend to be published in RL3 or RL4 
journals, papers describing clinical research appear in RL1, RL2 and RL3 journals with, as 
expected, few appearing in RL4 journals. This finding broadly supports the validity of the 
calculation of Research Levels by CHI Research Inc although, as expected, indicates that it 
might not be valid in all cases.  An additional complication is that these 2nd generation papers 
were published between 1981 and 2001, but the Research Level assigned to each journal is 
fixed and does not reflect possible changes in the character of the journal (Lewison and Paraje, 
2003). 
 
3.5.5 The research setting 
Where they were available, the research settings of the 2nd generation papers were examined 
using two address field filters. The UNIV/COLL/SCH filter identified academic addresses, and 
HOSP/INF/NHS was used for NHS sites. Three hundred and thirty-nine papers had an academic 
address and 215 papers had an NHS address, but of these 131 had both. The level of research 
represented in the papers with just one type of setting is shown in Figure 15. There were 84 
                                                          
4 Basic research-  theoretical or laboratory studies;  Clinical research-  relating to the observation and/or 
treatment of human subjects with a view to improving human health. 
 
 
 Figure 14: Research Level vs Article class for 2nd generation articles 
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papers with just an NHS address, 77 (92%) of which were describing clinical research and 208 
papers with just an academic address, 137 (66%) of which were describing clinical research. 
 
 
It has previously been assumed that research undertaken in a university setting is correlated with 
basic research whilst research undertaken in a hospital setting is correlated with clinical research 
(Grant et al, 2003).  Based on the evidence from this small body of work in the diabetes field, this 
assumption could be questioned and further investigation is warranted, particularly of the work 
emanating from university-based research. For example, collaborative research between 
university-based hospitals and academic departments within the university could well be 
important. 
 
3.6 Key findings 
3.6.1 Key observations about the payback 
The cited articles were judged to be of Considerable or Essential importance for only 9% of the 
623 2nd generation papers that were categorised. 
 
No significant relationship could be established between the number of times a paper was cited 
and the frequency of citations in which the cited article is classified as being of high importance. 
Self-citations, however, were significantly more likely than non self-citations to be classified as 
being of high importance. 
 
 
Figure 15: Analysis of clinical and basic research settings 
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It is quite striking that a few 2nd generation papers cited the 1st generation papers on multiple 
occasions and this was true for all 5 papers classified as Essential. 
 
Classification of the type of research (basic or clinical) by paper compared to the classification of 
the journal by Research Level is broadly in agreement although, as expected, there are some 
differences. 
 
3.6.2 Key lessons learnt about how to assess payback 
Using the literature it was possible to build a template for categorising citations. Work is still 
required to further define the various categorisations used in the template in a sufficiently 
unambiguous way to improve inter-assessor reliability. 
 
The considerable time required to apply the template, plus the lack of any overall pattern in terms 
of correlations between number and importance of citations, might point to the desirability of 
adopting a more selective approach aided by qualitative analysis. In any selective approach, 
however, it is likely that self-citations should feature. 
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4 QUALITATIVE ANALYSIS 
4.1 Introduction 
It was hoped that qualitative analysis would provide a fuller understanding of the processes by 
which research can influence subsequent studies and lead to wider benefits. Various qualitative 
approaches have proved useful when examining the impact that health services research has 
made on policy and practice, and on the career development of the researchers. These include: 
interviews with researchers, peers and other stakeholders; documentary analysis; and 
questionnaires to researchers (Buxton and Hanney, 1996; Buxton et al, 2000; Lavis et al, 2001; 
Hanney et al, 2003). In those studies it proved advantageous to start with a range of methods, 
and to be open to adopting extra assessment strategies as opportunities arose. This current 
study was intended to be a preliminary study and therefore it seemed particularly appropriate to 
test a range of methods and be flexible about adopting additional approaches. 
 
We initially proposed to use three main methods for the qualitative analysis: 
i. questionnaires to co-authors of all 29 papers from 1981—the 1st generation papers; 
ii. development of critical pathways by selected experts/peers; 
iii. interviews with researchers, peers and other stakeholders. 
 
Each of these is described in the following sections. In addition, Alberti, during a wide-ranging 
interview, raised the possibility of adopting an alternative strategy: examining the impact of a 
selection of key papers co-authored by him over a much longer period in the 1970s and 80s. This 
therefore eventually constituted an additional, fourth, approach:  
 iv.    analysis based on a selection of 10 key papers from Alberti.                                            
 
It was possible to incorporate analysis of these 10 papers into the interviews. This supplementary 
list also, however, helped to shed further light on, and contextualise, comments made in the 
critical pathways and questionnaires about the original 1981 outputs. The discussion of the 
results of the original methods is therefore informed by this additional approach; its 
methodological significance is further reviewed in the final chapter. This qualitative chapter 
describes an approach involving triangulation of both methods and data sources. The emerging 
findings and results from earlier parts of the study were built into the later design of interview 
schedules, and various points were tested on the interviewees. Following the account of the 
three original methods, an outline of the application of all four approaches is given. There is then 
a combined account of the significant findings. Some key observations linking findings and 
methods are made at the end of the chapter. 
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4.2 Methods: original plan 
4.2.1 Questionnaires to 1st generation co-authors 
Alberti’s research collaborations were widespread. We saw in section 2.3.3, for example, that the 
1981 list includes papers from all four main categories of Research Level, ranging from clinical 
observation to basic research. This breadth was also reflected in the number of co-authors 
involved in the 1981 papers: a total of 74. For such a large group a questionnaire approach 
seemed more appropriate than interviewing. The questionnaire was designed to cover a range of 
issues (see Appendix 6). It started with questions about the impact of the co-authored paper on 
subsequent research, before moving on to ask about any impact on policy, practice, commercial 
developments, or medical training. Finally, two more general questions cover the attraction of 
overseas researchers to Newcastle and overall impressions of the body of work from 1981. 
 
Alberti readily agreed that it would seem appropriate to seek the views of his co-authors. Home, 
as a member of the project’s Advisory Group, distributed the questionnaires from Newcastle, but 
confidentiality was guaranteed and the pre-paid reply envelope was to the Wellcome Trust.  
 
A questionnaire to the authors of the 2nd generation papers would have sought information on a 
range of issues that had been identified as important in our review of citation behaviour (Chapter 
3). Previous attempts to ask about such issues had, however, been conducted within a relatively 
short time of publication. Most of the authors we would have been approaching would have 
written their articles over ten years prior to receiving this questionnaire. Therefore, we concluded 
it would be difficult for them to answer many of the questions in which we were most interested. 
Furthermore, the analysis of the importance of the cited work in the citing paper was revealing 
that the citations that were still being given in the 1990s tended not to be rated as being of great 
significance. Therefore, the very authors who might have a clearest view about the issues in 
which we were interested, were the ones for whom the questionnaire would have least salience. 
 
4.2.2 Development of critical pathways by selected experts/peers 
The traditional assessment of research quality is left in the hands of peers. It was clearly highly 
desirable for this study to obtain the opinions of peers/experts. This exercise, however, was 
concerned with tracing the payback from research, rather than making an assessment of quality. 
The complexity of unravelling the impact of research is such that quite often an ‘insider account’ 
is seen as valuable (Phoolcharoen, 2002; Milbank Memorial Fund/the Cochrane Collaboration, 
2001).  Therefore, it seemed appropriate to commission at least one of the peer analyses from 
Home who had been a colleague of Alberti’s for many years, including in 1981. 
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The length of time over which the analysis was focusing meant that the most appropriate form of 
expert/peer review could be critical pathway analysis. Such analysis involves experts considering 
how lines or paths of research, and researcher careers, have evolved. Critical pathway analysis 
was undertaken as part of the Policy Unit’s study replicating Comroe and Dripps, but in the 
context of working backwards proved very difficult to do (Grant et al, 2003). For our study the 
experts undertaking the critical pathway analysis were asked to consider, in particular, the impact 
of each of the 29 papers on subsequent scientific advances and on health policies, practice, 
commercial exploitation and medical education (see Appendix 7). The instructions were 
deliberately not too prescriptive and the critical pathway authors were asked to detail the 
methods they adopted. An allocation of time of two days per critical pathway was suggested. 
 
4.2.3 Interviews with researchers, peers and other stakeholders 
Four interviews were conducted, face-to-face or by phone, and the interviewees each covered a 
number of perspectives.  Alberti not only gave his view on the impact of the body of work from 
1981, but also put it into wider perspective and discussed additional possible methods. Robert 
Tattersall is now an historian of diabetes, but previously was a leading academic clinician 
working at the same time as Alberti. The Director of Research at Diabetes UK, Moira Murphy, 
was previously a research scientist for a pharmaceutical company and in that capacity 
sometimes worked with the Newcastle team in the 1980s. She was also a member of the 
Department of Health/MRC Research Advisory Committee on Diabetes for the National Service 
Framework for Diabetes. Sue Roberts, too, was a member of that committee and of its Service 
Organisation and Delivery Subgroup. She is a leading consultant diabetologist, and winner of the 
Hospital Doctor of the Year Award in 1994, who has worked for many years in the North East of 
England, near to Alberti’s Newcastle centre. 
 
4.3 Results of applying the methods 
4.3.1 Questionnaires to 1st generation co-authors 
In total 24 questionnaires were returned and one was jointly completed by two co-authors who 
still work together. Many of the authors had collaborated with Alberti on more than one paper, in 
one case on as many as seven. Therefore, for some projects there was information from more 
than one questionnaire, and there was only one of the 29 papers for which there was no 
questionnaire completed. The information on the questionnaires varied enormously, however, 
with some respondents saying they did not think they had anything useful to contribute, to others 
who addressed all the questions and helpfully supplied some supplementary information. In 
preparation for the interviews, the questionnaire material relevant for each publication was 
combined with that from the critical pathway and the record of the number of citations.  
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4.3.2 Development of critical pathways by selected experts/peers 
A critical pathway was completed by Home and, as described in this section, its content broadly 
mirrored the suggestions set out in the guidelines contained in Appendix 7. It supplied 
information on every paper, although inevitably there was less detail about some of the papers 
where there had been little subsequent impact and/or the research was conducted primarily 
outside Newcastle or outside of the main areas of diabetes research. Home did not at this point 
have access to our detailed bibliometric and citation analysis on each paper. He started by 
adopting a formal assessment approach that covered a wide range of items for each paper. It 
soon became apparent to him that this would be too time consuming. Therefore, he reverted to 
asking three main questions of each paper: 
• Was there a discernible relationship between the paper and the first author’s career? 
• Did a body of research or commercial outcomes flow from the paper? 
• Was there a discernible clinical impact, either in general or through a guideline? 
 
As a result of considering these three questions Home was able to make a free text comment on 
each paper and a summary impact statement. In some cases it proved possible to group two or 
three papers together and make some general comments about them, for example, papers A7, 
A22 and A24 were grouped together under the heading human insulin. About them Home 
commented: ‘These were amongst the first papers on the pharmacokinetics and 
pharmacodynamics of human insulin...These papers, with a small number of others, were critical 
in providing the information that underpinned the introduction and early clinical trials of human 
insulin’. 
 
Home also observed, however, that the literature: 
‘is but a small part of the flow and understanding in any scientific area, and this is 
even more true as one moves to clinical practice. ...Most papers are like a new 
vegetable thrown into a pot of soup that is already in an advanced state of 
preparation—they may have an influence on the taste to varying extent, but it is the 
whole that generates the aromas that might influence the cook’s next action. 
Certainly the concept of any linear flow of activity is not applicable to this set of 
papers’. 
 
The task of independently constructing a critical pathway proved impossible for a more basic 
scientist in this field who was not a clinical diabetologist, and was abandoned. 
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4.3.3 Interviews with researchers, peers and other stakeholders 
Each interview took a somewhat different course, and the concentration was partially on feeding 
aspects and issues raised during previous interviews into later ones. The information from the 
questionnaires and critical pathways was used extensively, however, in structuring each 
interview. On many issues a reasonable degree of agreement was expressed, but there was 
marked divergence of views on a few issues. Alberti, too, took the view that generally science 
advanced by incremental steps and that it was difficult to pick out much that had made a real 
difference. He felt this was particularly true of the 1981 set of papers, whereas there were a few 
others during his career that perhaps had been of greater significance. These related, in 
particular, to two main areas. First, identifying new approaches to treatment for diabetic coma 
and for diabetics during surgery. Second, looking for new methods of treatment related to 
insulins. In both cases, Alberti, as noted in the introduction to the report, emphasised his 
approach of identifying clinical problems and then using basic science where necessary to help 
find a way forward. 
 
4.3.4 Analysis based on a selection of 10 key papers from Alberti 
As also noted above, Alberti felt that a list of 10 selected papers from the 1970s and 1980s might 
give a more appropriate picture of the payback from his work. He therefore subsequently 
selected 10 papers that, he felt, had had some impact on clinical practice. These are presented 
as Table 10, and numbered S1-S10.  The citations for each paper are shown on the table.  (In 
this way Table 10 combines the information that for the 1981 set of papers is contained in Table 
1 and Figure 3). Although the citation figures for the additional set have not been reduced by 
focusing on articles, notes and reviews only, as was undertaken for the 1st generation papers 
(see section 2.2.1 above), it is clear that these papers had an average citation rate about three 
times as high as the figure of 28 for the 1981 set.  
 
In the subsequent interviews, this additional list was also sent to interviewees prior to the 
interview and discussed. Tattersall, in preparing for his interview, drew on his knowledge of the 
history of diabetes to prepare what virtually amounted to a partial critical pathway for these 10 
papers. To some extent, the introduction of an additional list of papers distracted from the original 
purpose of the exercise.  However, it not only provided a fuller picture of Alberti’s work, it also 
created a context for understanding and assessing comments in some of the questionnaires that 
initially appeared to make rather substantial claims for some of the 1981 papers, but did so by 
saying they were part of a wider stream of work.  
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Various previous attempts by Diabetes UK to consider analysis of research impact indicated that 
it would be difficult to limit the approach to a single year. Furthermore, in practice, the additional 
papers did not take the exercise so far away from the original intention as might appear. Had the 
plan described in the initial project proposal proved practical, then a three year period would have 
been studied as described in the introduction. In this event, papers S5-S7 would have been 
included in addition to the 1981 paper already in both lists: S4/A7. Moreover, paper S8 was 
already in our 2nd generation and S10 would have been a 2nd generation paper from the 1981-83 
1st generation. 
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Table 10: KGMM Alberti ---10 Selected Publications from 1970s and 1980s Relevant for 
Clinical Practice 
 
S1.  Alberti KGMM, Hockaday TDR, Turner RC.  Small doses of intramuscular insulin in the 
treatment of diabetic "coma".  Lancet 1973; 2: 515-522.  Citations: 199 
S2. Pickup JC, Keen H, Parsons JA, Alberti KGMM.  Continuous subcutaneous insulin infusion: 
an approach to achieving normoglycaemia.   British Medical Journal 1978; i: 204-207.  
Citations:308 
S3  Alberti KGMM, Thomas DJB. The management of diabetes during surgery.     British Journal 
of Anaesthesia 1979; 51: 693-710.  Citations:70 
S4. Owens DR, Jones MK, Hayes TM, Heding LG, Alberti KGMM, Home PD, Burrin JM, 
Newcombe RG. Human insulin: study of safety and efficacy in man. British Medical Journal 1981; 
282: 1264-1266.  Citations:47 
S5. Worth R, Home PD, Johnston DG, Anderson J, Ashworth Linda, Burrin Jacqueline M, 
Appleton D, Binder C, Alberti KGMM. Intensive attention improves glycaemic controlin insulin 
dependent diabetes without further advantage from home blood glucose monitoring: results of a 
controlled trial. British Medical Journal 1982; 285: 1233-1240.  Citations:102 
S6.   Francis AJ, Home PD, Hanning I, Alberti KGMM, Tunbridge WMG. Intermediate acting 
insulin given at bedtime: effect on blood glucose concentrations before and after breakfast. 
British Medical Journal  1983; 286: 1173-1176.  Citations:56 
S7   Husband DJ, Alberti KGMM, Julian DG. "Stress" hyperglycaemia during acute myocardial 
infarction: an indicator of pre-existing diabetes? Lancet 1983; ii: 179-181.  Citations:37 
S8.  Elliott Martin J, Gill Geoffrey V, Home Philip D, Noy George A, Holden Michael P, Alberti K 
George MM. A comparison of two regimens  for the management of diabetes during open-heart 
surgery. Anesthesiology 1984; 60: 364-368.  Citations:7 
S9.  The Kroc Collaborative Study Group. Blood glucose control and the evolution of diabetic 
retinopathy and albuminuria: A preliminary multicenter trial. New England Journal of Medicine 
1984; 311: 365-372.  Citations:59 
S10. Gray CS, Taylor R, French JM, Alberti KGMM, Venables GS, James OFW, Shaw DA, 
Cartlidge NEF, Bates D. The prognostic value of stress hyperglycaemia and previously 
unrecognized diabetes in acute stroke. Diabetic Medicine 1987; 4: 237-240.  Citations:29 
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4.4 Findings from applying the four methods 
The combined sets of papers reveal examples where the impact is agreed to have been 
extensive, but also papers that fall into wide range of other situations.  As noted by Tattersall, the 
advantage of focusing on the papers from one year was that they provided a realistic picture of 
the large amount of research from any team that does not really lead anywhere.  There were, 
therefore, various advantages in having two lists. Given that the interviews drew upon the 
information from the other approaches, and that there is such a range of types of impacts from 
the research, it is appropriate for the analysis of the results of the four approaches to be merged 
into one section. Therefore, the section that follows is organised according to a number of 
categories of impact made by Alberti’s research. 
 
4.4.1 Examples of important basic research   
We here describe several of the 1981 papers that report basic research regarded as being of 
some significance in contributing to the development of the scientific field.  For these papers 
there is a mixture of both broad agreement but also some differences of emphasis about their 
exact contribution.  Paper A24 (see Table 1, p8) describes a study, conducted at the National 
Institute for Medical Research, Mill Hill, which Alberti played a major role in supervising. It 
examined the importance, in diabetic dogs, of portal and peripheral infusions of insulin. The 
findings seem to have been subject to slightly different interpretations, but the study is widely 
viewed as being an important one and it was suggested that the area has continued to be of 
scientific interest. This is because it is still thought that research into portal insulin delivery and 
hepato–specific insulin could eventually have positive clinical dividends. The comments are 
consistent both with the number of citations (37) being above the average for the 1981 set, and 
with the half-life for the citations, ie the year by which half the total citations had appeared, being 
slightly longer than average (see Figure 4, p13).  
 
The Newcastle based study of the metabolic effects of growth hormone, and the role of insulin in 
countering them (A18), is seen as quite an important basic physiological paper. It was cited 51 
times which made it the third most highly cited paper in the 1981 list (see Figure 3, p13). 
However, in terms of the classification given to the those citations (see Table 9, p36), for an 
above average number of the papers citing A18 the importance of its contribution was rated as 
only Peripheral. This paper was one of the occasions on which there appeared to be some 
divergence between the citation count and the view expressed in the critical pathway, which was 
that the research impact was not great. The large number of citations in which the contribution 
was seen as Peripheral might help explain this; it might also be compatible with Alberti’s view 
that some of the ketone body studies from 1981 were interesting but would not have had any 
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4.4.2 Basic research of diverse significance 
There was considerable variation in the extent to which a range of other basic studies, either 
conducted at Newcastle or for which Alberti’s team did the measurement of metabolites, led onto 
subsequent research or were cited. Some of them did, however, contribute to the overall body of 
knowledge. For some of them the techniques in use in our study produced even more differing 
messages than those given in the above example.  
 
Paper A3 describes basic research involving the metabolism of somatosatin and its analogues by 
rat liver. With 47 citations it was jointly the fourth most highly cited paper of the 1981 set and one 
of the co-authors described its importance to some specific later papers. Furthermore, checking 
the classification that had been given to these specific citations revealed that paper A3 was 
indeed thought, in our categorisation process, to have been of considerable importance to these 
citing authors. Tattersall saw it as an interesting paper that did not seem to have had many 
clinical or practical consequences, and the research area appeared to have been one that had 
fizzled out. Despite this, the half-life of the paper was also the fourth longest out of the 1981 set, 
but again an above average number of its citations were seen as Peripheral (see Table 9). This 
is compatible with the impression of the team member undertaking the scoring of the citations 
that many citations were referring to a method of measuring the rate of degradation using talc, 
and that this had not seemed a particularly important point. This contrasts with some of the 
previous attempts to categorise citations that were described in section 3.2.4. In these, any 
citations appearing in the methods section of a paper would automatically be given a higher 
score for location than other citations would receive, irrespective of the content. Our less 
mechanistic approach suggests citations in any location are best judged on their individual 
merits.  
 
In contrast to the divergent evidence about paper A3, there was agreement between all the 
methods on the limited impact of paper A19. This study examined the liver metabolites in resting 
and exercising rats at 1 and 4 bar. It was cited just once and that was classified as being of only 
peripheral importance to the citing paper. 
 
4.4.3 Research with major and rapid clinical impact 
There is complete agreement between the various data sources for the qualitative study that 
paper A5, describing the management of diabetes during open heart surgery, made a significant 
and continuing impact on clinical practice. According to Tattersall, for example, it was ‘very 
important’. It is also claimed that it made an impact on subsequent research in the field and that it 
identified a new problem. For our study, therefore, it is most interesting to note that the paper 
received only 10 citations, well below the average figure for the set. Partly this is explained by it 
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relating to improvements in the management of diabetes during open-heart surgery, which is a 
comparatively small clinical field. Nevertheless, had our study relied solely on citation analysis 
the significance of this paper would have been overlooked. A full understanding of its contribution 
comes from looking at Alberti’s selected list of papers from the longer period. 
 
Paper S3, from that list, examined the management of diabetes in surgery generally.  It is seen 
by Tattersall as ‘a very important paper’ which provides ‘a comprehensive review of the 
literature’. There were many diverse ideas around at the time about how best to manage 
diabetes during surgery. This review finished with suggested guidelines that had a considerable 
impact on practice by establishing that the glucose-potassium-insulin regimen first developed by 
Sodi-Pallares should be applied in this context. It also strongly argued for anaesthetists using 
near patient methods to measure glucose. Some clinicians adapted the idea and used their own 
delivery mechanism, but many applied the Alberti technique. Paper A5, therefore, can now be 
seen as applying, to the specific context of the long period involved in open heart surgery, the 
ideas developed by Alberti and Thomas a few years previously in paper S3.  Similarly, paper S8 
was seen as a development of A5 and one that tested a particular piece of equipment, the 
biostator, during open heart surgery. In addition to being on Alberti’s selected list, S8 was, as 
noted above, one of our 2nd generation papers. Despite the importance of the stream of work, 
paper S8, too, had a low citation rate: the figure of 7 citations was well below that of most of the 
papers on the 1981 list, let alone those on the S list. 
 
The paper by Alberti and colleagues on small doses of intramuscular insulin in the treatment of 
diabetic coma, S1, also enjoyed rapid and extensive application. According to Tattersall it was 
influential in Europe in the movement away from giving large doses of insulin. Roberts, for 
example, read it as a Senior House Officer and regarded it as very important – she still 
occasionally refers clinicians to it. Again the provision of quite detailed recommendations for 
treatment probably helped account for its considerable impact. Murphy contrasted the benefits 
from this situation with that for children, where it had taken a long time before equivalent 
guidelines had been produced. Furthermore, with 199 citations paper S1 has clearly had 
considerable impact on subsequent research.  
 
The significance of both papers S1 and S3 lies in their clinically relevant recommendations that 
had immediate and long-lasting impact. Paper S1 represented quite a significant break from 
previous work, although Sönksen and colleagues were also exploring somewhat similar things at 
the same time (see, for example, Sönksen et al, 1972). In the case of S3, in particular, there was 
clearly much preceding work, but it was the ability to build on that work to make the clinically 
relevant recommendations that was so important. 
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4.4.4 Early clinical research of mixed immediate impact but major long-term 
importance 
The studies considered here, A26, A8, and S2, were part of a collaboration between Newcastle 
and Guy’s and perhaps come nearest to the model implied in the original application from the 
Wellcome Trust/Brunel. The consequences of the work described in these papers can be traced 
through various generations. They can be seen to have had considerable impact on subsequent 
research that is now, in turn, impacting on practice. The story is far from straight forward, 
however, and again it is not really possible to comprehend the full picture by limiting the analysis 
to the 1981 papers. Paper A26 describes a study showing that for provision of insulin before 
meal times a ‘bolus’ delivery was optimal. The study was of some importance in its own right and 
received 39 citations. It was, however, part of a much wider stream of work on continuous 
subcutaneous insulin infusion using a subcutaneous pump. 
 
Paper S2 is one of the main papers describing the origin of using subcutaneous pumps and it 
resulted from Alberti’s collaboration with Mill Hill, where John Parsons used such pumps for more 
basic research, and with colleagues at Guy’s who were conducting research into diabetes. Paper 
S2 could perhaps best be described as early clinical research. This paper has been cited over 
300 times and various comments about paper A26 were clearly related to the flow of subsequent 
research that resulted from the work described in a series of papers from the 
Guy’s/Newcastle/Mill Hill team in the late 1970s and early 1980s. In particular, the pump 
addressed the issue of insulin delivery in a controlled way that mimicked insulin secretion in non-
diabetics. Major research projects were undertaken to examine the clinical benefits that might 
come from the consequent improvements in blood glucose control.  
 
The international study funded by the Kroc Foundation is seen as flowing from this stream of 
work.  This was a prospective multicentre randomised trial to determine both the feasibility of 
maintaining improved blood glucose by using continuous subcutaneous infusion using pumps, 
and the effect of the improved control on diabetic microangiopathy and albuminuria. Newcastle 
provided the central laboratory for this Anglo-North American study, and Alberti was one of the 
authors of the key paper describing the project. This appears on the selected list as S9, but the 
explicit reference in this paper to the work on subcutaneous pumps is neither A26 nor S2, but 
another paper from the Guy’s/Newcastle team, namely Pickup et al, 1979. This paper, which was 
slightly later than S2, was probably used as the key reference in the Kroc study because it 
described the use of pumps in a way that was nearer to the approach adopted in the Kroc study. 
This means that the Kroc study was not in our 2nd generation papers and, had we identified it 
through bibliometric methods, it could only have appeared in a later generation. 
  54 
The importance of the Kroc study is that it is seen as a crucial step towards the National 
Institutes of Health (NIH) funded multi-centred Diabetes Control and Complications Trial (DCCT). 
The Kroc study concluded: ‘These preliminary observations indicate the need for longer trials’ 
(The Kroc Collaborative Study Group, 1984, p. 365). The Kroc paper, S9 in Alberti’s list, is cited 
early in the main DCCT paper (DCCT Research Group, 1993). All interviewees agreed that the 
results from the DCCT have had a major impact on diabetes treatment in recent years by 
demonstrating that improved control over blood glucose and blood pressure leads to undoubted 
benefits in terms of reduced likelihood of complications. It is often difficult for databases 
accurately to record citations to papers whose authorship is a group. Nevertheless, this paper 
seems to have at least 870 citations recorded in various ways. There was wide agreement about 
the importance of the contribution of the Newcastle/Guy’s collaboration to this stream of work. 
 
In addition to informing a major stream of research, the Guy’s/Newcastle work more directly fed 
into clinical practice in two ways. First, subcutaneous pumps have been refined as a way of 
delivering insulin and paper A26, according to one of the co-authors, might have influenced the 
commercial development of pumps because of its focus on bolus delivery at meal times. Pumps 
have been introduced more widely in the USA and the rest of Europe than in the UK, despite 
having been invented in the UK. The issue of pumps was recently investigated by the National 
Institute for Clinical Excellence (NICE). The Diabetes UK submission to NICE stated that less 
than 0.2% (or 650 people) with type 1 diabetes use pumps in the UK compared to about 8% in 
the USA, and 12% in Sweden. An article by Home et al (1982) is one of the papers cited in the 
submission as showing the benefits from pumps; this paper, in turn, cites three of the 1981 
papers and so appears in our 2nd generation. Having itself been cited about 70 times it would 
have been an important 1st generation paper under our original plan of taking a three-year period.  
 
In the recent guidance from NICE, insulin pump therapy ‘is recommended as an option for people 
with type 1 diabetes provided that: 
• Multiple-dose insulin (MDI) therapy (including, where appropriate, the use of insulin 
glargine) has failed; and 
• Those receiving the treatment have the commitment and competence to use the therapy 
effectively’ (NICE, 2003, para 1.1). 
 
The guidance goes on to state that the view of the Appraisal Committee was that ‘the proportion 
of people with type 1 diabetes who would be appropriate for, and would take up, insulin pump 
therapy, would be in the order of 1% to 2% of the total’ (NICE, 2003 para 4.3.10).  Nicely 
rounding off this discussion is the fact that the DCCT is one of the studies cited in the appraisal 
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consultation document from NICE as showing the benefits of maintaining good glycaemic control 
(NICE, 2002). 
 
The second direct clinical impact linked to the stream of work on pumps is more controversial 
and is described in paper A8. The hypothesis tested in this Guy’s/Newcastle paper was that for 
the diabetic patients with the most unstable glucose control, known as brittle diabetics, there was 
a physiological reason why the insulin was not being absorbed properly. The pumps were 
relevant in that they could be used to improve the administration of insulin. Brittle diabetic 
patients from around the country were taken on by Guy’s and Newcastle. Tattersall described 
how he took a different view and always believed the causes of brittle diabetes were 
psychological not physiological. He suggested that this was now the accepted view. This was 
clearly a major debate in research relevant for clinical practice, and paper A8 has been fairly 
widely cited (44 times). 
 
4.4.5 Studies of commercial relevance  
Various studies were relevant for pharmaceutical companies and device manufacturers. They 
include: A7/S4; A22; A27; A13; A28; and A29. Despite the common commercial link, the nature 
of these studies varied. 
 
Alberti described A7 and A22 on the Novo semi-synthetic human insulin as being ‘very basic 
studies on pharmacokinetics’. There is wide agreement about the technical competence of these 
studies, and Murphy felt that some of the stream of such studies from Newcastle provided 
methodological developments that indicated how such studies should be undertaken in the 
future. Paper A27, in a similar area to that of A7 and A22, pioneered a new way of assessing the 
comparative efficacy of insulin preparations. However Tattersall, in particular, argued that the 
work in A7 and A22 was more in the nature of routine testing. Certainly in the critical pathway, 
Home notes that the large literature that followed was similarly stimulated by funding from the 
pharmaceutical companies. The quite high citation rates partly reflect the level of funding for 
further studies in these areas. The companies themselves were responsible for the clinical 
introduction of human insulin, which was so rapid that it was sometimes controversial. 
Nevertheless, studies such as these meant the companies could claim that the proper testing 
had been undertaken. (The studies did not show that semi-synthetic human insulin actually 
provided better results, but rather that there was no difference in clinical outcomes between using 
human and animal insulin). 
 
In terms of research that flowed from these studies, Home describes how the studies gave an 
enormous push to the understanding of the problems and needs of subcutaneous insulin therapy 
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and, therefore, there is a clear link with the stream of work described in the preceding sub-
section. Papers A7 and A27 were quite highly cited—42 and 41 times respectively. Furthermore, 
these two, plus A22, all contained a below average number of citations where the importance of 
the cited paper to the citing papers was classified as Peripheral.  This was particularly noticeable 
for A27 (where it was down to 19%) and the percentage of citations of high importance was the 
second highest, also at 19%--though four of the six were self-citations. The impact of this work, 
however, was perhaps rather concentrated because A7, A 22, and A27, also all had some of the 
shortest half-lives out of the 1981 set. A further point that might be of generic relevance but was 
claimed specifically in relation to these papers, is that two of the authors, Owens and Home, 
have been leading international and UK lecturers on insulin therapy for many years. Presumably, 
producing early, successful and reasonably highly cited papers in a field provides the credibility 
to be invited to lecture, and further citations might flow from this. 
 
Paper A13, describing the testing of the slowing of carbohydrate absorption by acarbose, has the 
highest number of citations in the 1st generation. Furthermore, a below average number of these 
were classified as Peripheral.  This partly reflects the fact that this was seen as a good basic 
study in the development of the drug, and one published in a journal with a high impact factor 
score. But it is also related to the history of acarbose. Shortly after this paper was published a 
study linked acarbose to cancer in rats, which stopped further development. Some years later 
this was found to be untrue; so it came back on stream and is now thought to have a potentially 
important role.  Given this long history it is not surprising that paper A13 has one of the longest 
half-lives. One of the co-authors suggested that this paper was linked to the licensing of 
acarbose.  
 
Paper A29 was one of a large number at this time testing different ways of conducting aspects of 
home blood-glucose monitoring. It is suggested it had some impact on the techniques developed 
by manufactures and used by practitioners. Paper S5 cites A29 and is therefore a 2nd generation 
paper. It demonstrates the important point that it was not so much the fact that it was blood 
glucose, rather than urine, monitoring that gave the advantage so much as the extra attention 
and information patients were receiving. Again, despite the agreement that this was an important 
finding, there was some disagreement about how the paper should best be interpreted in terms 
of clinical practice. 
 
Paper A28 addressed the issue of meal-time insulin delivery in the context of testing its injection 
by a gun or jet. The reported findings about the limited advantages of using the gun, which was 
being heavily marketed, probably helped slow wider distribution: the findings were incorporated 
nto guidelines. In the critical pathway it was argued that, along with paper A26, it was one of the 
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first to measure insulin profiles in plasma after injection, which has since become routine in such 
studies. Furthermore, it is suggested that the insulin profiles from A28 are still being used by 
some lecturers to illustrate the profile of human/pork insulin absorption after injection of meal-
time insulin. These factors might explain why, despite the negative findings which are usually 
associated with short half-lives, in fact this paper had the third longest citation half-life of all 29 
papers. 
 
4.4.6 Studies that disproved an existing theory 
Paper A23 describes one of the first of several studies that disproved the Chlorpropamide alcohol 
flushing hypothesis. As Home notes, this raises interesting issues in terms of payback because it 
was an important study that had an impact, but one that stopped a line of inquiry. The relevance 
of this interpretation is seen in the citation figures which are just above average, but which have 
the shortest half-life. 
 
4.4.7 Other studies on the selected list and the overall link to clinical practice 
Tattersall saw paper S7 as being important because it showed, probably for the first time, that 
raised blood glucose levels at the time of myocardial infarction indicate diabetes not transient 
“stress hyperglycemia”. By contrast, and illustrating well the point that much research represents 
small incremental steps, Tattersall suggested that paper S6 added only a little to something he 
had reported a couple of years earlier (Tattersall and Gale, 1981) as being part of his practice. 
 
Roberts argued that the flow of studies from the Newcastle team had had a considerable 
influence on clinical practice, especially in the North East. She suggested that S6 was one 
example of that. She did not always think it appropriate to follow exactly the research findings 
from Newcastle and, as with the approach to surgery, sometimes developed her own method of 
implementing the approach. In this way there was more local ownership of the implementation. 
Nevertheless, the influence on clinical practice, which was of course national and international as 
well, was particularly strong in the Newcastle region. This was because of various factors 
including: the training of doctors who took up posts locally; the seminars etc run by the Newcastle 
team; and the role of Alberti as a respected opinion leader. Alberti himself acknowledged that 
there had been something of a ripple effect. There is some debate in general about the link 
between clinical and academic excellence, but both Alberti and Tattersall stressed its  
importance. Alberti was instrumental in securing resources for a Newcastle Diabetes Care Centre 
that concentrated the diabetes care in the city on a dedicated centre. In 1999 it won the Diabetes 
Centre of the Year Award. Examples of the international impact on clinical practice included ones 
from a co-author who referred to the influence on clinical guidelines from the Italian Society for 
the Study of Diabetes. 
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4.4.8 Impact on career development and medical education 
Reference was made in Chapter One to the payback model that is informing this study. A key 
element in this is the research training that can be gained through participation in research 
projects (Buxton and Hanney, 1996; Buxton et al, 2000). Similarly, attention has recently focused 
on evaluating the social and economic benefits from publicly funded basic research by examining 
the mobility of scientists, particularly as they move into the commercial sector (Zellner, 2002). 
Home, in his critical pathway, was able to identify at least nine of the lead authors of the 1981 set 
of papers, including himself, for whom the involvement in this body of research provided a sound 
basis for subsequent career development. Similar points were made in interviews and by various 
co-authors in the questionnaires. One, for example, described the experience as, ‘valuable 
training for the subsequent 110 papers/projects’. Though much of this came from the training 
received at Newcastle, there were also, as with paper A24, benefits from Alberti’s wider links. 
Ralph Stevenson, the lead author of paper A24, is a notable example of a researcher who later 
moved into the commercial sector: he eventually became head of diabetes research at Pfizer.  
 
Some of those from overseas who spent time in Newcastle also described the benefits to them in 
glowing terms. Generally, those who came from overseas were seen as good researchers, 
usually in the early stages of their careers. They often made a positive contribution to the 
portfolio of research at Newcastle. 
 
The questionnaire to co-authors elicited a range of responses to the question about the 
contribution to medical training that was derived from the research. There was an overlap 
between discussion of the personal training received and the use of the findings in teaching. In 
addition to the points discussed above, several co-authors gave specific examples of where they 
thought the research had fed into medical education—again not just in the UK. 
 
4.5 Key findings from the qualitative analysis 
4.5.1 Key observations about the payback from the body of work 
Attempting to describe the impact from the 1981 body of work, and that from the 10 selected 
papers, underlines the complex reality of how science advances and influences clinical practice. 
Many papers, if they make a contribution at all, make a small, incrementalist one.  A few papers, 
however, have been shown to make a considerably greater impact. A possible key to the level of 
payback indicated is the enormous breadth of Alberti’s contacts, and fields and methods of 
working. This is well illustrated in the account of how the idea for subcutaneous pumps came 
about. Similarly, perhaps, and as mentioned above, the ability to produce the very important 
guidelines on treating diabetics during surgery, and diabetic coma, partly resulted from the 
application to clinical problems of the understandings gained from some of the basic/early clinical 
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studies.  What is significant in relation to the key papers S1, S2, and S3 is that they were having 
an impact on the work of 1981.  
 
What perhaps is less clear from our study is an overall feel for how far the collection of papers 
from 1981 have been drawn upon in ways that would match these examples. Nevertheless, even 
here, paper A5, on treating diabetics during open heart surgery, and paper A26, on bolus delivery 
of insulin at meal times, are key parts of these wider streams. Furthermore, various papers, 
including A13 on acarbose, A24 on portal infusion of insulin, and A7 on semi-human insulin, have 
been shown to be important steps in bodies of work in their respective areas. Finally, the full 
complexity of the issues was summed up by paper A23 that helped to debunk the 
Chlorpropamide alcohol flushing hypothesis, and thus end a line of scientific enquiry.  
 
4.5.2 Key lessons learnt about how to assess payback 
On reflection, 1981 perhaps did not provide a really coherent starting point for this preliminary 
study despite it being relatively close to the time when Alberti moved to Newcastle. This was not 
only because of the large number of collaborations that he kept up, but also because important 
work that had been undertaken a few years earlier was still overlapping with the 1981 work. 
 
However, the alternative approach of 10 selected papers, chosen from a longer period, is also 
problematic in various ways. For example, the omission of the paper cited in the Kroc study 
shows that not all the key links could come from analysis restricted to just the papers on such a 
list. Furthermore, the list of 10 papers also does not do justice to the full range of Alberti’s work: it 
excludes, for example, a more basic Lancet paper (Alberti, 1973) that has had over 500 citations 
and much other important work, including studies related to Africa and more recent activities. 
(However, our study was never intended to review the full payback from the whole career of such 
a leading researcher). Looking at it from an opposite angle, however, such a list of selected 
papers might underplay the extent to which many studies have a very limited impact, if any. 
 
Nevertheless, the variety of methods used has been successful in demonstrating a range of 
points. The relationship between qualitative analysis and bibliometrics is not simple, but there do 
seem to be benefits from combining the approaches, as was suggested by Gläser and Laudel 
(2001). The benefits come in various forms. The importance of the surgery papers despite their 
relatively low citation rates illustrates that analysis of citations alone is not sufficient, 
notwithstanding the fact that surgery papers tend on average to receive fewer citations than 
papers in the diabetes field (Wellcome Trust/NHS Executive, 2001). Furthermore, some of the 
more highly cited papers are revealed to be ones that are not necessarily included in those seen 
in the qualitative study as being of most significance. Some of the qualitative analysis, therefore, 
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shows bibliometrics is not sufficient. Other aspects of the qualitative approach, however, are 
strengthened by comparison with bibliometric data. For example, information on citation half-lives 
is providing useful correlations with some of the accounts from interviews etc. Similarly, 
comments in some of the interviews, and questionnaires, about the breadth of Alberti’s 
collaborations correlate well with the discussion, in section 2.3.5, of the number of addresses per 
paper for the 1981 set being above average.  
 
It is more difficult, however, to develop ways of fully utilising the extensive categorisation of the 
citations that was undertaken in Chapter Three. The figures for the importance of cited papers to 
the citing paper are difficult to link precisely to the qualitative analysis. There is some indication, 
however, that analysis of the importance of citations provides a better correlation with some of 
the comments made in the qualitative analysis than comes from crude citation counts alone. 
Evidence from the citation counting and categorisation is compatible with the view that a wide 
range of basic research is produced but only some of it eventually makes a significant 
contribution. The picture is, as yet, far from clear, but, nevertheless, some points are emerging. 
In any attempt to trace research through to its influence on practice, self-citations should certainly 
not be discounted in the way that happens in some assessments. Discounting self-citations 
would have meant, for example, not including the 1981 work that was cited in Home et al (1982) 
which, as noted, was eventually cited in the evidence from Diabetes UK to NICE on insulin 
pumps. While self-citations are not an illustration that peers regard the work as being worthy, the 
categorisation of citations suggests that self-citing can be an important way in which research 
findings are taken forward. 
 
The contribution from the historical perspective provided by Tattersall also proved to be of great 
value, and this is consistent with those who advocate the use of an historical approach in 
examining the benefits from health research (Raiten and Berman, 1993; Berridge and Stanton, 
1999). The significance of this contribution comes in several ways. On some issues, especially in 
relation to the treatment of brittle diabetics, the longer and wider perspective is useful in 
demonstrating that the implementation of some research findings is not always thought to be 
beneficial. But more generally, the historical approach helps to provide the realistically broad 
perspective within which the contribution of any one individual or team should be examined. It is 
interesting to note that while drawing on such a perspective, which often serves to reduce the 
significance of the contribution of an individual researcher, Tattersall was able to highlight various 
areas where Alberti’s work had been of considerable importance. 
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5 LESSONS LEARNT AND THE WAY FORWARD 
The three approaches used in this study have produced a large amount of data as reported in the 
previous chapters. Here we briefly review what we have learnt, describing the advantages and 
disadvantages to each approach, and make some overall assessments, before suggesting how 
the methods could be taken forward into a large-scale study as conceived at the outset of this 
preliminary project. 
 
5.1 Lessons learnt about the exercise 
We have used a combination of quantitative (bibliometric) and qualitative (case study) techniques 
to illustrate how a body of research published by George Alberti 20 years ago, in 1981, impacted 
on clinical practice in subsequent years.  To do this we tested three methodologies:  
 
• Citation tracing 
For the bibliometric analysis it was possible to trace the research through several 
generations, and then use these generations to conduct further bibliometric analysis 
including on the Research Levels of the generations, half-lives of the citations, and the 
number of authors and addresses on papers. It was possible to correlate some of this 
data with the qualitative analysis in ways that did illuminate various issues. 
 
A major problem, however, was that, as with the previous attempts to work backwards, 
the number of papers rapidly became too large to handle. The original application had 
stated that it might be impractical to go beyond the 4th generation; as it turned out it was 
not possible to go beyond the 3rd generation. Had a similar pattern of growth occurred as 
happened between the 2nd and 3rd generations, the 4th generation would have consisted 
of at least 100,000 papers. 
 
• Categorisation of citations 
The review of the literature on citation behaviour and categorising citations was utilised in 
the production of a template. The template was piloted by six assessors. The inter-rater 
reliability proved to be rather variable, but it was sufficiently satisfactory for one assessor 
to apply the template to the remaining citing articles. The ensuing categorisation provided 
some data that assisted with the interpretation of some comments made in the qualitative 
analysis. Furthermore, the extensive analysis has shed some light on the nature of 
citation behaviour. Self-citations to this body of work were, on average, categorised as 
being more important to the citing author than were citations given by other authors. 
Partly this arose from the nature of the extra authority that seems to accompany self-
citations.  
  62 
Additional work will be required to refine the template for citation categorisation, and the 
ways in which it is applied, before it is used more widely. Furthermore, given the time 
required to apply the template, plus the apparent lack of any overall pattern in terms of 
correlations between number and importance of citations, it would seem desirable to 
adopt a selective approach towards categorising citations.  
 
• Qualitative study  
The qualitative analysis was able to produce a reasonably coherent account of the range 
of payback from the body of work examined. There was more impact on clinical practice 
than the study might have been expected to uncover, and considerable impact through 
research training was demonstrated. All the interviews produced useful material, and did 
so from a variety of perspectives, but the ability of an historian of diabetes to place 
Alberti’s contributions within an historical analysis was of particular value. It is probably 
worth recommending that any future such analysis attempt to incorporate this perspective 
and the flexibility that it provides. That this important contribution came from one of 
Alberti’s peers is also consistent with another key observation: having the insider expert 
from Newcastle to undertake the critical pathway analysis provided extremely valuable 
insights and detail. 
 
It became clear in the qualitative phase that there were difficulties in undertaking critical 
pathway analyses, which restricted the number produced. Furthermore, there were so 
many 1st generation co-authors that it was impractical to interview them. Questionnaires, 
however, were successfully used instead.  
 
• Overall assessment 
The variety of methods used has been successful in demonstrating a range of points. In 
some cases the additional methods are revealing things that a single approach could 
have missed. The importance of the surgery papers despite their relatively low citation 
rates illustrates that simple analysis of citations alone is not sufficient. Furthermore, some 
of the more highly cited papers are revealed to be ones that are not necessarily included 
in those seen in the qualitative study as being of most significance. Nevertheless, the use 
of multiple approaches is also helping to strengthen the analysis where points from one 
technique reinforce those from others. For example, some of the detailed bibliometric 
analysis, such as that on citation half-lives, is providing useful correlations with some of 
the other accounts from interviews etc. Martin and Irvine (1983) developed the concept of 
‘converging partial indicators’ which involve the use of a range of indicators when 
considering the quality of teams of researchers operating in expensive areas of ‘big 
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science’. Our combination of techniques suggests there are advantages in using a range 
of techniques when attempting to trace the impact from basic, or early clinical, bio-
medical research. Furthermore, the evidence from this study suggests it might be 
potentially useful to begin to look for correlations in relation to the breadth of work 
conducted by a research team, the levels of collaboration, the role of core funding 
support, and the degree of influence on clinical practice. So, for example, material from 
our interviews describes how Alberti believes in the benefits from undertaking a wide 
range of studies. The evidence from the analysis of Research Levels, and the qualitative 
analysis, demonstrates the breadth of Alberti’s portfolio of research. Other bibliometric 
analysis highlights the large number of collaborators with whom he worked. And all this 
can be considered in the light of the analysis in Chapter Four indicating the impact made 
by this body of research. 
 
What is proving more difficult, however, is to develop ways of fully utilising our extensive 
categorisation of the citations that resulted in the figures for the importance of the cited 
papers to the citing paper. On reflection, 1981 perhaps did not provide a really coherent 
starting point for this preliminary study despite it being relatively close to the time when 
Alberti moved to Newcastle. This was not only because of the large number of 
collaborations that he kept up, but also because important work that had been undertaken 
a few years earlier was still overlapping with the 1981 work. 
 
Nevertheless, it is reasonable to conclude that whilst some difficulties were encountered 
with each approach, and some matters need addressing at an overall level, sufficient 
progress has been made to warrant considering how to take the study forward. 
 
5.2 From preliminary to large-scale study 
Various issues need to be addressed as we move towards a large-scale study. These include: 
 
• Refining the techniques  
Further development and refinement of some of the methods will be undertaken as 
support is sought for the large-scale study. This will include attempting to improve the 
consistency of application of the categorisation of citations, and testing the ideas 
proposed below for applying the quantitative methods in a selective manner to key papers 
identified in the qualitative study. As a further preliminary step therefore, we will initially 
explore these activities in relation to the data already gathered in the study. Furthermore, 
we shall aim to incorporate improved techniques being developed elsewhere, including a 
new method of determining journal Research Levels (Lewison and Paraje, 2003). 
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• Defining the research questions 
As described in Chapter One, our study objective was to develop and test a number of 
methodologies.  We therefore did not have a specific research hypothesis to test, beyond 
examining the assumption that basic research does feed through into eventual impact on 
clinical practice. However, in moving towards a large-scale study, we may want to focus 
on specific policy-relevant issues such as identifying and comparing factors that are 
associated with the successful translation of basic and early clinical research into clinical 
science and application. The preliminary study indicated several factors that could be 
included in the analysis. These relate to how far the production of research that is 
transferred into practice is connected to: the breadth of work undertaken; the number of 
collaborators; and support from core funding. 
 
• Focus of the study 
In the current study we focused on one research group (Alberti) from one point in time 
(1981). If we expand the scope of the study (as suggested above) then it will be 
necessary to test the reliability and validity of any factors that are associated with, say, 
the successful translation of research.  To give confidence in our findings, we will need to 
expand the focus of the study, to cover at least four sets of case studies. Ideally, each set 
of case studies should focus on the work of a number of research groups in the same 
field, in the same country. Our sets of case studies would cover two or three different 
fields, hopefully in at least two different countries.   
 
5.3  Proposal for a large-scale study 
If we increased the scope and focus of the study as suggested, some initial work would be 
necessary to select the case studies.  For each case study we would have two methodological 
elements, qualitative and quantitative, which would work in parallel, each informing the other, to 
provide data for a research report. 
  
Qualitative research 
The qualitative aspect of a future large-scale study would be to develop an oral history of a 
research group’s composition, key previous work of group members, the research programme in 
the early 1980s, and then trace the research originating from the group over a 20 year time 
period.  To do this we propose to use a number of qualitative methods including: 
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• Group review 
We would need to inform ourselves of the work of the selected research groups by: 
reviewing all the literature published by the research groups, be that in the serial peer-
reviewed literature or (where available) the ‘grey’ literature, contemporary commentators 
(for example editorials) and retrospective historical accounts (for example from the history 
of medicine literature); reviewing archival material from the research funders (such as 
original project proposals, referees’ comments etc) and the researchers themselves; 
developing (with the help of ‘field experts’) critical pathways of the research group’s 
outputs and contributions to career development. 
   
• Key informant interviews 
We would need to try to interview the original members of the research group, their 
collaborators, and others who might know about the impact of the research.  The 
interviews will cover the formation of the group and its research and, using the ‘payback 
model’, the long-term impacts of the research, including: contributions to clinical 
guidelines or other policies or health promotion schemes; uptake of the findings by 
industry; and influence of the research on medical training and clinical practice. 
 
• Workshop 
For each case study we could run a workshop where we would invite a sample of the 
interviewees and other relevant stakeholders.  The workshop could be run along the line 
of the Wellcome Trust’s Witness Seminar Series to explore chronologically the 
development of research originating from the research group.   
 
• Describe ‘research lines’ 
Using the primary and secondary resources from the document review, the key informant 
interviews and the workshop, it should be possible to piece together a detailed oral history 
of a case study’s research programme and its impacts over a 20 year period.  In addition, 
the identification of ‘research lines’ – that is discrete bodies or themes of research each 
addressing a particular question pursued by the research group – around the payback 
model would allow the application of standard comparable multidimensional indicators.   
 
• Study seminar 
For all cases on the same topic there could also be a seminar at which the various time-
lines would be discussed, in particular the overlaps between the research lines and 
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research groups. Whether such a seminar would cover the research in the field of more 
than one country would depend on the nature of the emerging findings.  
 
Quantitative bibliometric analysis 
We would propose to use bibliometric data to inform and validate our qualitative research. The 
quantitative methods would include: 
 
• Citation tracing for ‘research line’ papers 
Using the techniques reported in Chapter Two, we could develop a citation trace for 
‘research lines’ identified from case study research. Initially this activity would start in 
conjunction with the ‘group review’ described above. To overcome the issue of 
exponential growth in our citing papers, however, we could – for each generation – focus 
our analysis on a core set of papers that were explicitly identified and referenced in the 
‘research line’, and their ‘parental’ papers, as illustrated in Figure 16.  By taking this type 
of approach we would be able to use the results of our qualitative study to focus our 
bibliometric analysis on the key citation trace through a research line.  
  
 
Figure 16: Schema illustrating citation tracing for research line papers 
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• Categorisation of key papers 
We would need to refine the survey instrument for categorising papers, and test its inter-
rater reliability.  However, it could then be applied to the papers that cite the key papers 
from our research line.   
 
Presenting the findings 
Each research line could be written-up in a standardised document describing the impact of that 
research using the HERG payback model and categories (Buxton and Hanney, 1996).  In 
addition, we would be able to describe a quantitative citation trace, using bibliometric techniques, 
for a research line and a randomly generated control.  We shall use the qualitative and 
quantitative data to compare and contrast the ‘payback’ of research lines by country, disease and 
identify common factors that correlate with the translation of basic or early clinical research.  
 
 
5.4 Concluding comments 
The approach we have reported in this study is innovative and challenging.  In the era of 
‘evidence based policy’ research funders, as with all other sectors of society, are looking for 
value for money in the research they support.  This means that they need to understand the 
effectiveness of different research strategies.  This in itself poses a number of challenges, not 
least because the translation of new knowledge into improved policy and/or practice and 
commercial and non-commercial outcomes occurs over a long time period. 
 
In this study we have begun developing a methodology that will allow us to understand the 
complexity of research development over a generation.  The utility of the type of policy research 
proposed here will only be realised when it is scaled up to cover a number of different fields in 
different settings.  This type of benchmarking study using comparative cases should allow the 
identification of factors that are common to, say, the successful translation of research.  This in 
itself could inform research funders on their contemporaneous strategies, thereby increasing the 
likelihood of research getting into practice and thus increasing its effectiveness.  
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Appendix 1: Funding sources for each paper 
 
Paper 
Reference 
Number 
Sources of Funding  
A1 None 
A2 Synthelabo (Paris); British Diabetic Association 
A3 The Wellcome Trust; British Diabetic Association 
A4 British Diabetic Association; Newcastle Area Health Authority 
A5 None 
A6 British Diabetic Association; Medical Research Council (UK) 
A7 Novo Industries 
A8 British Insulin Manufacturers; Medical Research Council (UK); Novo Ltd; 
Minet Trust; British Diabetic Association 
A9 Newcastle Area Health Authority; British Diabetic Association; ; Medical 
Research Council (UK); The Wellcome Trust 
A10 British Diabetic Association; The Wellcome Trust 
A11 British Diabetic Association 
A12 None 
A13 Bayer UK; British Diabetic Association; Medical Research Council (UK); The 
Wellcome Trust 
A14 Novo Industries; British Diabetic Association 
A15 British Diabetic Association; Newcastle Area Health Authority (Teaching) 
A16 Royal Victoria Hospital Belfast Research Fellowship; British Diabetic 
Association 
A17 British Diabetic Association; The British Council; Novo Industries 
A18 None 
A19 British Diabetic Association 
A20 British Diabetic Association; The Wellcome Foundation (Trust?) 
A21 Danish Medical Research Council 
A22 Novo Industries 
A23 [Pfizer Ltd materials]; Northern Regional Health Authority; British Diabetic 
Association 
A24 British Diabetic Association 
A25 British Diabetic Association; The British Council; Novo Industries, Denmark 
A26 Servier Laboratories; National Institutes for Health; Novo Laboratories; British 
Insulin Manufacturers; British Diabetic Association 
A27 Eli Lilly 
A28 Novo Laboratories Ltd 
A29 British Diabetic Association; Newcastle Area Health Authority (Teaching); 
[Medistron Ltd and Boehringer Corporation Ltd for the modified Glucocheck 
meter] 
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Appendix 2: Guidance notes for completion of the datasheet 
 
We are assessing the “payback” from research as part of an NHS Executive-funded project and 
are collecting information on the relationships between cited and citing articles.  You have been 
provided with one datasheet per citing reference and a copy of the citing article. The following 
notes are provided for your guidance but if you need further clarification on completing this 
datasheet please contact Iain Frame on 020 7611 8235 or e-mail i.frame@wellcome.ac.uk 
 
• The cited article details are given at the top of the datasheet.  Locate the cited reference 
details in the references section at the end of the article and mark it.  Depending on the 
journal, references are cited in different ways.  Some journals cite articles by all authors, 
some by first author (or first three authors) followed by et al, and some use a numbering 
system where the articles cited are numbered either in the order they appear or alphabetically 
by author. 
 
• You should be aware that prior to 1985, the ISI Science Citation Index gives author details in 
the following order- first author followed by all other authors in alphabetical order.  You may 
therefore find that the details on the datasheet don’t match up exactly with the details in the 
references section of the paper. 
 
• Locate the citations by reading through the article, marking where each citation occurs.  As 
far as possible, try to fit the location into one of the categories provided (eg Introduction, 
Materials and Methods, Results or Discussion) 
 
• When recording individual citation details, you should mark each individual citation, even 
when it occurs twice in the same sentence or paragraph. 
 
• For each citation occasion you may tick more than one box according to the definitions 
provided. 
 
• When assessing the overall importance of the cited article to the citing article, please use the 
following definitions for guidance.  In cases where there is more than one datasheet per citing 
article, please answer the additional question relating to the overall importance of the body of 
work as a whole according to the definitions given below. 
 
PERIPHERAL:  The work described in the cited article is of little importance to the citing article. 
Citation is simply background, an aside, for completeness or indeed irrelevant. 
 
LIMITED: The work described in the cited article is of some limited importance to the citing 
article. It would be inappropriate to omit it, but it is not an important part of a central argument. 
 
CONSIDERABLE: The work described in the article is of considerable importance to the citing 
article. The work is one of a number central to the argument. 
 
ESSENTIAL:  The work described in the cited article is of critical importance to the citing article, 
and central to the argument presented, and a key foundation for the paper. 
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Appendix 3: Template for categorising articles 
 
Cited Paper ID: A6 
Authors: Barnett-AH Alberti-KGMM Burrin-J Pyke-DA Spiliopoulos-AJ Stubbs-WA 
Title: Metabolic Studies in Unaffected Co-Twins of Non-Insulin-Dependent Diabetics 
Journal: BRITISH MEDICAL JOURNAL Vol: Vol 282         Pages:  pp 1656-1658 
Addresses: UNIV LONDON KINGS COLL HOSP, DEPT DIABET, LONDON SE5 9RS, ENGLAND/ST 
BARTHOLOMEWS HOSP, DEPT MED, LONDON EC1A 7BE, ENGLAND/ROYAL 
VICTORIA INFIRM, DEPT CLIN BIOCHEM & METAB MED, NEWCASTLE TYNE NE1 
4LP, TYNE & WEAR, ENGLAND 
 
Citing Paper ID: B1 
Title:  Metabolic Studies in Unaffected Co-Twins of Non-Insulin-Dependent Diabetics 
Authors: Hockaday-TDR 
Journal: BRITISH MEDICAL JOURNAL 
Individual citation details 
For each occasion the article is cited, note its location (eg Introduction, Materials and Methods, Results or 
Discussion) in the citing article. 
For each citation, tick the appropriate box(es) using the following definitions: 
 
Develop: The citing article is developing a concept or method previously described in the cited article. 
Support: The citing article is supporting a concept or method previously described in the cited article. 
Apply:  The citing article uses a method (or methods) described in the cited article. 
Refute: The citing article either claims that the cited article is incorrect or disputes the cited article but is 
unable to come to a firm conclusion. 
Note/Review The citing article refers to the cited article as part of the relevant literature but it either 
serves  
Only:  no explicit role in the analysis (note) or is compared to other relevant literature 
(review). 
 
 
Citation 
occasion 
Location Develop Support Apply Refute Note/ 
Review  
only 
1st       
2nd       
3rd       
4th       
5th       
6th       
Additional citations … 
 
 
Articles class:    Basic    Clinical 
Does the article describe basic research (ie theoretical or laboratory studies) or clinical research (ie 
relating to the observation and/or treatment of human subjects with a view to improving human health). 
 
 
 
What is the overall       Peripheral    Limited   Considerable    Essential 
importance of the cited      Tick one box which you think is the most appropriate. 
article to the citing article?: 
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Appendix 4: Template for categorising reviews 
 
Cited Paper ID: A28 
Authors: Taylor-R Alberti-KGMM Home-PD 
Title: Plasma Free Insulin Profiles After Administration of Insulin by Jet and Conventional Syringe 
Journal: DIABETES CARE  Vol: Vol 4 Pages: pp 377- 379 
Addresses:  
 
Citing Paper ID: B1020 
Title:  The Absorption of Subcutaneously Injected Insulin 
Authors: Demeijer-PHEM Lutterman-JA Vantlaar-A 
Journal: NETHERLANDS JOURNAL OF MEDICINE 
 
1.3 Individual citation details 
For each occasion the article is cited, make a judgement whether the citation lies in the introduction, 
conclusion or elsewhere in the article.   
 
For each citation, tick the appropriate box(es) using the following definitions: 
 
Support: The citing article is supporting a concept or method previously described in the cited 
article. 
 
Refute: The citing article either claims that the cited article is incorrect or disputes the cited article 
but is unable to come to a firm conclusion. 
 
Note/Review The citing article refers to the cited article as part of the relevant literature but it either  
Only: serves no explicit role in the analysis (note) or is compared to other relevant literature 
(review). 
 
 
Citation 
occasion 
Location Support Refute Note/ 
Review  
only 
1st     
2nd     
3rd     
4th     
5th     
6th     
Additional citations … 
 
 
 
What is the overall        Peripheral  Limited  Considerable     Essential 
importance of the cited       Tick one box which you think is the most appropriate. 
article to the citing article?: 
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Appendix 5: Location and category of the citation occasions in five papers in the Essential group  
 
   Location of citation 
Cited  
paper ie  
1st generation 
Citing  
paper ie  
2nd generation  
No of 
citation 
occasions 
Introduction Materials & 
Methods 
Results Discussion Elsewhere* 
A20 B152 9 4 Note/Review - - 3 Support 
2 Refute 
N/A 
A20 B157 6 1 Note/Review - - 5 Support N/A 
A23 B65 6 1 Note/Review 
2 Refute 
N/A N/A N/A 1 Note/Review 
2 Refute 
A24 B175 8 1 Note/Review 
 
2 Support 
and Apply** 
- 5 Support N/A 
A8 B31 7 2 Support 2 Apply 1 Support 2 Support N/A 
* Location classification for review articles 
** 2 citations judged to be both Support and Apply 
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Appendix 6: Questionnaire to original authors 
 
1. What is your impression of the ways, if any, in which the paper(s) you co-authored with Sir 
George Alberti influenced subsequent scientific research by yourself or others? 
 
 
 
 
 
 
 
 
 
 
 
 
 
2. Are you aware of any papers that gave a citation, or self-citation, to your paper(s) and that 
turned out to be particularly significant in terms of the development of a scientific line of 
enquiry? 
Yes ≺    No ≺  
 
If so, please give the reference of the citing paper if possible: 
 
 
 
 
 
 
 
 
 
3. Are you aware of any impact that your paper(s) has had directly, or through further research 
by yourself and/or others, on eventual policy and/or practice, for example contributing to: 
national or local policies including clinical guidelines and health promotion schemes; or 
changes in the behaviour of practitioners at the national or local level? 
Yes ≺    No ≺ 
 
If yes, please give examples: 
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4. Are you aware of any patents, or other commercial products, to which the research described 
in your paper(s), or in papers citing it, contributed? 
Yes ≺    No ≺ 
 
If yes, please give details: 
 
 
 
 
 
 
 
 
 
5. Are you aware of any contribution to medical training that was derived from the research 
described in your paper(s), or in research building on it? 
Yes ≺    No ≺ 
 
If yes, please give details: 
 
 
 
 
 
 
 
 
 
6. Apart from those appearing on the enclosed Table of 1981 co-authors, are you aware of any 
senior overseas researchers attracted to undertake a period of research in the UK as a result 
of the stream of work at Newcastle conducted by Sir George and his team? 
Yes ≺    No ≺ 
 
If so, please give details: 
 
 
 
 
 
 
 
 
7.  Are there any other observations you would care to make about the overall body of work 
contained in the set of 1981 papers in the Table? 
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Appendix 7: Critical pathway instructions 
 
Professor George Alberti’s scientific output in 1981 included the attached 29 articles.  We would 
like you to construct a critical pathway exploring the impact of this work in terms of the 
subsequent scientific advances and the impact on health.  
 
It might be appropriate to start with a rapid review of the papers to decide: 
a) which papers have had the greatest impact on health; and 
b) is it possible to group the papers into perhaps 4 or 5 major areas (possibly identifying a key 
paper to represent each group) and continue the main analysis on that basis. 
 
If a number of pieces of published work are related it would also be useful to provide a 
terminology (e.g. ‘methods of insulin delivery’) for the Wellcome Trust/HERG research team to 
use to describe these groups of papers. 
 
As guidance to undertaking the main analysis it may be useful to think first about the impact the 
scientific knowledge represented in these papers has made on subsequent scientific advances, 
whether made by the original authors or by other teams. Then it would be helpful to consider 
whether these paper (or groups of papers) have had impact on any of the following: national or 
local policies including clinical guidelines/health promotion schemes; the medical education 
provided at Newcastle or elsewhere; local or national clinical practice; commercial exploitation 
etc. 
 
We have deliberately not made these instructions too prescriptive, it would therefore be helpful if 
you could briefly detail the methodology you used to perform the task. 
 
